###begin article-title 0
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast Screens Identify the RNA Polymerase II CTD and SPT5 as Relevant Targets of BRCA1 Interaction
###end article-title 0
###begin p 1
Conceived and designed the experiments: AG JM CB. Performed the experiments: CB TW CV TS HP GH AS EM DB AF YM. Analyzed the data: JM CB. Contributed reagents/materials/analysis tools: AG CB HP AG JO. Wrote the paper: AG JM CB.
###end p 1
###begin p 2
###xml 307 331 307 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 733 755 733 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPT4, SPT5, CTK1, DEF1</italic>
###xml 793 846 793 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ASM4, MLP1, MLP2, NUP2, NUP53, NUP120, NUP133, NUP170</italic>
###xml 848 861 848 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NUP188, POM34</italic>
###xml 903 913 903 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR4, DHH1</italic>
###xml 954 955 954 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 996 997 996 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 1004 1005 1004 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1013 1014 1013 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</italic>
###xml 1101 1105 1101 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DEF1</italic>
###xml 307 331 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 1302 1307 <span type="species:ncbi:4932">yeast</span>
###xml 1363 1368 <span type="species:ncbi:9606">human</span>
###xml 1524 1529 <span type="species:ncbi:4932">yeast</span>
###xml 1534 1539 <span type="species:ncbi:9606">human</span>
BRCA1 has been implicated in numerous DNA repair pathways that maintain genome integrity, however the function responsible for its tumor suppressor activity in breast cancer remains obscure. To identify the most highly conserved of the many BRCA1 functions, we screened the evolutionarily distant eukaryote Saccharomyces cerevisiae for mutants that suppressed the G1 checkpoint arrest and lethality induced following heterologous BRCA1 expression. A genome-wide screen in the diploid deletion collection combined with a screen of ionizing radiation sensitive gene deletions identified mutants that permit growth in the presence of BRCA1. These genes delineate a metabolic mRNA pathway that temporally links transcription elongation (SPT4, SPT5, CTK1, DEF1) to nucleopore-mediated mRNA export (ASM4, MLP1, MLP2, NUP2, NUP53, NUP120, NUP133, NUP170, NUP188, POM34) and cytoplasmic mRNA decay at P-bodies (CCR4, DHH1). Strikingly, BRCA1 interacted with the phosphorylated RNA polymerase II (RNAPII) carboxy terminal domain (P-CTD), phosphorylated in the pattern specified by the CTDK-I kinase, to induce DEF1-dependent cleavage and accumulation of a RNAPII fragment containing the P-CTD. Significantly, breast cancer associated BRCT domain defects in BRCA1 that suppressed P-CTD cleavage and lethality in yeast also suppressed the physical interaction of BRCA1 with human SPT5 in breast epithelial cells, thus confirming SPT5 as a relevant target of BRCA1 interaction. Furthermore, enhanced P-CTD cleavage was observed in both yeast and human breast cells following UV-irradiation indicating a conserved eukaryotic damage response. Moreover, P-CTD cleavage in breast epithelial cells was BRCA1-dependent since damage-induced P-CTD cleavage was only observed in the mutant BRCA1 cell line HCC1937 following ectopic expression of wild type BRCA1. Finally, BRCA1, SPT5 and hyperphosphorylated RPB1 form a complex that was rapidly degraded following MMS treatment in wild type but not BRCA1 mutant breast cells. These results extend the mechanistic links between BRCA1 and transcriptional consequences in response to DNA damage and suggest an important role for RNAPII P-CTD cleavage in BRCA1-mediated cancer suppression.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 338 341 338 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Venkitaraman1">[1]</xref>
###xml 841 844 841 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Venkitaraman1">[1]</xref>
###xml 844 847 844 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Zhong1">[2]</xref>
###xml 994 997 994 997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Wang1">[3]</xref>
###xml 997 1000 997 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Chiba1">[4]</xref>
###xml 1000 1003 1000 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Greenberg1">[5]</xref>
###xml 1212 1215 1212 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Venkitaraman1">[1]</xref>
Inherited heterozygous BRCA1 and BRCA2 defects have been associated with an enhanced risk of early onset breast cancer. These tumor suppressor genes normally function to maintain genome integrity by participating in the repair of DNA damage. Although the repair-related functions of BRCA1 have been extensively characterized (reviewed in [1]), identifying the underlying mechanism responsible for the onset of breast cancer has remained elusive. The BRCA1 protein functions in multiple pathways that maintain genomic integrity through its impact on the repair of a variety of genomic lesions including DNA double-strand breaks (DSBs). BRCA1 participates in recombinational repair of DSBs, non-homologous end-joining of DSBs, checkpoint arrest, transcriptional regulatory mechanisms and chromatin remodeling as well as centrosome duplication [1][2]. Moreover, the BRCA1 protein has been found to physically interact with numerous other proteins in distinct, multi-component DNA repair complexes [3][4][5]. Although BRCA1 seems to be a central DNA repair component due to its many physical interactions in repair-related processes, the tumor suppressor activity is largely confined to breast and ovarian epithelia [1]. To resolve this enigma, BRCA1 has been suggested to interact with a subset of tissue specific, non-redundant cofactors in a single key pathway to mediate its tumor suppressive effects.
###end p 4
###begin p 5
###xml 98 123 98 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae,</italic>
###xml 312 315 312 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Resnick1">[6]</xref>
###xml 473 476 473 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Humphrey1">[7]</xref>
###xml 489 492 489 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Westmoreland1">[8]</xref>
###xml 693 696 693 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Humphrey1">[7]</xref>
###xml 92 97 <span type="species:ncbi:4932">yeast</span>
###xml 98 122 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 317 322 <span type="species:ncbi:4932">Yeast</span>
###xml 508 513 <span type="species:ncbi:4932">yeast</span>
As an alternative approach for studying this important repair protein, we have utilized the yeast Saccharomyces cerevisiae, which has served as the fundamental model organism for the identification of the genetic controls associated with DNA repair and checkpoint functions that are conserved in most eukaryotes [6]. Yeast is an excellent model organism for elucidating BRCA1 function since heterologous expression of BRCA1 causes slow growth and lethality in both haploid [7] and diploid [8] wild type (WT) yeast. Mutations within the BRCT domain of BRCA1 that are associated with familial breast cancer, but not polymorphisms without disease association, suppress this slow growth phenotype [7].
###end p 5
###begin p 6
###xml 658 661 658 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Willingham1">[9]</xref>
###xml 663 667 663 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Giorgini1">[10]</xref>
###xml 968 972 968 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR4</italic>
###xml 976 980 976 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DHH1</italic>
###xml 1056 1059 1056 1059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Westmoreland1">[8]</xref>
###xml 161 167 <span type="species:ncbi:9606">humans</span>
###xml 172 177 <span type="species:ncbi:4932">yeast</span>
###xml 198 203 <span type="species:ncbi:4932">yeast</span>
###xml 757 762 <span type="species:ncbi:4932">yeast</span>
###xml 815 820 <span type="species:ncbi:4932">yeast</span>
In order to identify a key pathway that may underlie the tumorigenic potential of BRCA1 in breast cancer, we took advantage of the evolutionary distance between humans and yeast. In effect, we used yeast as an evolutionary "filter" to identify conserved proteins that, through severe functional constraints, have maintained the ability to interact with BRCA1 over a vast evolutionary distance. Other successful examples of this approach include the identification of relevant conserved genetic and biochemical networks that interact with mutant Huntington protein as well as alpha-synuclein, which has been implicated in the pathology of Parkinson's disease [9]; [10]. Since interaction of BRCA1 with such conserved proteins may account for lethality in WT yeast, we screened for nonessential gene deletions in the yeast diploid deletion collection that suppressed BRCA1-induced lethality. Previously, we described that deletions of the G1 checkpoint adaptation genes CCR4 or DHH1 that also mediate radiation resistance, suppressed BRCA1-induced lethality [8].
###end p 6
###begin p 7
###xml 567 570 567 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C t</italic>
###xml 578 579 578 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</italic>
###xml 594 599 594 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNA p</italic>
###xml 714 715 714 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 722 725 722 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTD</italic>
###xml 910 912 910 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de</italic>
###xml 922 923 922 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</italic>
###xml 929 933 929 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DEF1</italic>
###xml 938 943 938 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTK1,</italic>
###xml 100 105 <span type="species:ncbi:4932">yeast</span>
###xml 404 409 <span type="species:ncbi:9606">human</span>
###xml 473 478 <span type="species:ncbi:9606">human</span>
###xml 1133 1138 <span type="species:ncbi:4932">yeast</span>
###xml 1143 1148 <span type="species:ncbi:9606">human</span>
In this report we screened both ionizing radiation (IR) sensitive mutants and an unselected pool of yeast deletion mutants to identify additional suppressors of GAL-induced BRCA1 lethality. Many of these suppressors are functionally and temporally linked in mRNA metabolic processes that include transcriptional elongation, mRNA export and decay. Focusing on the process of elongation, we demonstrate in human cell extracts that BRCA1 can be co-immunoprecipitated with the human ortholog of Spt5p and hyperphosphorylated RNAPII. We show that BRCA1 interacts with the C terminal domain (CTD) of RNA polymerase II (RNAPII) when the CTD is phosphorylated in a pattern specified by the CTDK-I kinase (CTK), to mediate phospho-CTD (P-CTD) cleavage. This P-CTD cleavage is not induced by cancer-associated mutations in the BRCT domain (C-terminal domain of BRCA1) and is suppressed by genomic deletion of the RNAPII degradation factor DEF1 and CTK1, the CTD kinase that results in phosphorylation of serine 2 and serine 5. We further show that UV-irradiation results in a proteasome dependent accumulation of the P-CTD cleavage product in yeast and human breast cancer cells wild type for BRCA1 but not in a BRCA1 mutant cell line. Ectopic expression of the wild type BRCA1 protein in this mutant line restores damage dependent P-CTD cleavage indicating a direct mechanistic link between BRCA1 and this newly discovered RNAPII processing event. From this and other supportive data, we propose a model in which BRCA1-induced RNAPII P-CTD cleavage and degradation is a key component of a highly conserved, checkpoint/surveillance pathway that detects DNA damage within actively transcribing genes.
###end p 7
###begin title 8
Results
###end title 8
###begin title 9
###xml 67 72 <span type="species:ncbi:4932">yeast</span>
A genome-wide screen for suppressors of BRCA1-induced lethality in yeast identifies genes required for mRNA elongation, export and decay
###end title 9
###begin p 10
###xml 52 65 52 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. cerevisiae</italic>
###xml 472 477 472 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 763 772 763 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g001">Fig. 1A,B</xref>
###xml 843 848 841 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.,</italic>
###xml 915 922 911 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g001">Fig. 1C</xref>
###xml 1145 1153 1141 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001448.s001">Table S1</xref>
###xml 46 51 <span type="species:ncbi:4932">yeast</span>
###xml 52 65 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 90 95 <span type="species:ncbi:4932">yeast</span>
###xml 192 197 <span type="species:ncbi:4932">yeast</span>
###xml 265 270 <span type="species:ncbi:4932">yeast</span>
###xml 1121 1126 <span type="species:ncbi:4932">yeast</span>
Although a BRCA1 ortholog is not found in the yeast S. cerevisiae, expression of BRCA1 in yeast results in slow growth and lethality. We reasoned that an interaction of BRCA1 with a conserved yeast protein(s) interferes with a basic cellular function essential for yeast survival and that these proteins would be intimately involved in the maintenance of genomic integrity. By screening for rapid growth on GAL-URA (GAL) medium immediately following transformation of the BRCA1 expression plasmid into a pool of genetically tagged deletion strains, we initially identified a total of 48 mutant strains that suppressed BRCA1 lethality. Typically upon screening, the WT strain containing the BRCA1 plasmid failed to grow on GAL beyond the first or second dilution (Fig. 1A,B) and the relative colony forming survival fraction was 0.098+/-0.089 (i.e., 90.2% of WT cells fail to survive BRCA1 induction; n = 33+/-1 SE; Fig. 1C). Of the 48 deletion strains that were initially identified to suppress BRCA1, 20 (42%) were subsequently confirmed to suppress lethality greater than 2 fold over WT in an independently transformed yeast deletion isolate (Table S1).
###end p 10
###begin title 11
###xml 89 94 <span type="species:ncbi:4932">yeast</span>
Identification and characterization of genetic suppressors of BRCA1-induced lethality in yeast.
###end title 11
###begin p 12
###xml 300 305 300 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAL::</italic>
###xml 763 808 763 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">apt1&#916;, nst1&#916;, oca1&#916;, ygr039W&#916;</italic>
###xml 813 825 797 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ylr412W&#916;</italic>
###xml 921 930 901 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bbc1&#916;</italic>
###xml 935 947 911 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ygr064W&#916;</italic>
###xml 981 985 953 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPT4</italic>
###xml 1166 1177 1138 1149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NUP2, POM34</italic>
###xml 1182 1186 1154 1158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MLP2</italic>
###xml 1249 1271 1221 1243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NUP120, NUP170, NUP188</italic>
###xml 1283 1289 1255 1261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NUP133</italic>
###xml 1302 1310 1274 1282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001448.s001">Table S1</xref>
###xml 1396 1398 1368 1370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 1422 1430 1394 1402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001448.s001">Table S1</xref>
###xml 1454 1464 1426 1432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nup84&#916;</italic>
###xml 1617 1621 1585 1589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPT4</italic>
###xml 1625 1629 1593 1597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTK1</italic>
###xml 1725 1727 1693 1695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 1789 1793 1757 1761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPT4</italic>
###xml 1797 1801 1765 1769 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTK1</italic>
###xml 1900 1909 1868 1873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">spt4&#916;</italic>
###xml 1931 1940 1895 1900 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ctk1&#916;</italic>
###xml 2048 2068 2002 2014 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">spt4&#916;, def1&#916;</italic>
###xml 2073 2082 2019 2024 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ctk1&#916;</italic>
###xml 2415 2422 2357 2364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
###xml 2678 2738 2620 2660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nup2&#916;, nup120&#916;, nup133&#916;, nup188&#916;, pom34&#916;</italic>
###xml 2742 2751 2664 2669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mlp2&#916;</italic>
###xml 3002 3022 2920 2932 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">spt4&#916;, ctk1&#916;</italic>
###xml 3027 3036 2937 2942 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">def1&#916;</italic>
###xml 3053 3058 2959 2964 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAL::</italic>
###xml 3304 3306 3210 3212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 3445 3450 3351 3356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAL::</italic>
###xml 3456 3460 3362 3366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HIS3</italic>
###xml 3491 3493 3397 3399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 2479 2484 <span type="species:ncbi:4932">yeast</span>
(A) Suppression of BRCA1-induced lethality following transformation of isogenic deletion strains with BRCA1 plasmid. BRCA1 suppressor strains were initially identified by sequencing rapid growing strains arising on GAL-URA plates following transformation of the diploid deletion strain pool with the GAL::BRCA1 expression plasmid. Putative BRCA1 suppressor strains identified from the pool were selected from the arrayed deletion strain library and transformed with the BRCA1 expression plasmid, grown to stationary phase in GLU and 2 ul aliquots were replica spotted onto GLU and GAL plates from serial 5-fold dilutions in water (arrows indicate direction of decreasing cell concentration). Typical results are depicted for seven strains. Five deletion strains (apt1Delta, nst1Delta, oca1Delta, ygr039WDelta and ylr412WDelta) failed to suppress BRCA1 lethality and were omitted from further study. Two deletion strains, bbc1Delta and ygr064WDelta (which deletes the N terminus of SPT4) were confirmed to suppress BRCA1-induced lethality. (B) Deletion strains defective in mRNA export suppress BRCA1-induced lethality. Deletions of the nuclear pore associated genes NUP2, POM34 and MLP2 (from deletion pool) and deletions of the IR resistance genes NUP120, NUP170, NUP188 as well as NUP133 (not shown, Table S1) suppress BRCA1 lethality. Relative plating efficiencies for colony formation on GAL vs GLU (GAL/GLU) are from Table S1. With the exception of nup84Delta, all IR sensitive nuclear pore defective strains significantly suppressed BRCA1-induced lethality. (C) Deletion of the transcriptional elongation genes SPT4 or CTK1 completely suppress BRCA1-induced lethality. Reduced colony forming ability on GAL (Galactose) vs GLU (Glucose) plates is completely suppressed by deletion of SPT4 or CTK1 when compared to WT strains containing the BRCA1 plasmid. Plates depicted are following 3 (WT and spt4Delta strains) and 4 days (ctk1Delta) incubation at 30degreesC. (D) Suppressor strains defective in transcription elongation express BRCA1. WT, spt4Delta, def1Delta and ctk1Delta strains containing the BRCA1 expression plasmid were induced in liquid GAL for the indicated times (hrs). Western blot has been probed with anti-BRCA1 antibody MS110. Full-length BRCA1 has an apparent MW of 220-250 kDa or larger (arrow). (E) Nuclear exclusion of BRCA1 is not responsible for suppression of BRCA1-induced lethality. In situ immunofluorescence of BRCA1 was determined in uninduced yeast cells (GLU) or induced for BRCA1 expression for 6 hours (GAL). Hoechst staining was used to position the nucleus. No partitioning defects were observed for BRCA1 in other nuclear pore mutants (nup2Delta, nup120Delta, nup133Delta, nup188Delta, pom34Delta or mlp2Delta; data not shown) that suppressed BRCA1 lethality. In all cells examined, BRCA1 was localized to both the nucleus and cytoplasm. Bar is 10 um. (F) Suppression of BRCA1-induced lethality is not due to second site suppressors. Diploid deletion strains (spt4Delta, ctk1Delta and def1Delta) containing the GAL::BRCA1 expression plasmid were "covered" with the corresponding gene expressed from a second selectable plasmid and assayed for the reinstatement of BRCA1 lethality by determining the relative plating efficiencies of colony forming ability on GAL vs GLU with selection for both plasmids. WT+BRCA1 (-HIS) is the relative survival of colony forming ability for the WT strain containing the GAL::BRCA1-HIS3 expression plasmid on GAL-HIS vs GLU-HIS medium. Error bars are +/- 1 SD about the mean and each bar represents 3-6 experiments.
###end p 12
###begin p 13
###xml 116 120 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Bennett1">[11]</xref>
###xml 120 124 120 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Westmoreland2">[12]</xref>
###xml 184 192 184 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001448.s001">Table S1</xref>
###xml 210 219 210 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dhh1&#916;</italic>
###xml 224 233 220 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ccr4&#916;</italic>
###xml 275 278 267 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Westmoreland1">[8]</xref>
###xml 280 289 272 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">def1&#916;</italic>
###xml 351 355 339 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Reid1">[13]</xref>
###xml 462 471 450 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">yml009c-a</italic>
###xml 476 485 464 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">yml009w-b</italic>
###xml 514 518 502 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPT5</italic>
###xml 734 756 722 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DEF1, SPT4, SPT5, SUB1</italic>
###xml 772 828 760 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MLP2, ASM4, NUP2, NUP120, NUP133, NUP170, NUP188, POM34;</italic>
###xml 828 835 816 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g001">Fig. 1B</xref>
###xml 886 896 874 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DHH1, CCR4</italic>
###xml 1011 1019 999 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001448.s001">Table S1</xref>
As a secondary screen, we also examined the 203 deletion strains that we previously found to be radiation sensitive [11][12]. Thirteen of these were found to suppress BRCA1 lethality (Table S1). These included dhh1Delta and ccr4Delta, previously characterized as suppressors [8], def1Delta which is involved in RNAPII degradation following DNA damage [13], a number of nuclear pore proteins required for mRNA transport, as well as two open reading frames (ORFs; yml009c-a and yml009w-b) that overlap the 3' end of SPT5 to truncate the protein. We collectively identified mutants with defects in highly conserved cellular processes that primarily affect mRNA metabolism. Specifically, these processes include transcription elongation (DEF1, SPT4, SPT5, SUB1), mRNA export (MLP2, ASM4, NUP2, NUP120, NUP133, NUP170, NUP188, POM34;Fig. 1B) and mRNA decay at cytoplasmic processing bodies (DHH1, CCR4). Using these screening approaches, we identified a total of 36 deletion strains that suppressed BRCA1 lethality (Table S1).
###end p 13
###begin p 14
###xml 291 299 291 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001448.s001">Table S1</xref>
###xml 457 466 457 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mlp1&#916;</italic>
###xml 471 481 467 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nup53&#916;</italic>
###xml 591 600 583 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ctk1&#916;</italic>
###xml 605 615 593 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">srb10&#916;</italic>
###xml 617 627 601 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ssn3&#916;)</italic>
###xml 826 834 806 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001448.s001">Table S1</xref>
###xml 92 97 <span type="species:ncbi:4932">yeast</span>
Extensive genome-wide proteomic and genetic interaction networks have been characterized in yeast. We utilized these interaction networks (listed at SGD) to determine whether genes or gene products that genetically or physically interact with experimentally identified suppressors of BRCA1 (Table S1) could identify additional deletion mutations that suppress BRCA1 lethality. Using known network interactions, we identified a further 9 deletions including mlp1Delta and nup53Delta as suppressors of BRCA1. Moreover, genetic interactions of BRCA1 with RNAPII elongation components predicted ctk1Delta and srb10Delta (ssn3Delta) as suppressors of BRCA1-induced lethality due to their impact on RNAPII C-terminal domain (CTD) phosphorylation (described below). Thus a total of 45 suppressors of BRCA1 lethality were identified (Table S1).
###end p 14
###begin title 15
Suppression of lethality is not due to reduced BRCA1 expression, nuclear exclusion or second site suppressors
###end title 15
###begin p 16
###xml 536 557 536 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 712 719 712 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g001">Fig. 1D</xref>
###xml 848 857 848 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">spt4&#916;</italic>
###xml 886 897 882 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nup170&#916;</italic>
###xml 949 956 941 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g001">Fig. 1E</xref>
###xml 1046 1050 1038 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPT4</italic>
###xml 1052 1056 1044 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTK1</italic>
###xml 1061 1065 1053 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DEF1</italic>
###xml 1212 1219 1204 1211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g001">Fig. 1F</xref>
Since suppressors of BRCA1 lethality could have an impact upon mRNA expression and export or nuclear import of the BRCA1 protein, we analyzed representative strains for BRCA1 expression and subcellular localization. Following a standard whole cell extraction protocol using ice-cold NP40 buffer, BRCA1 was extensively degraded even in the presence of protease inhibitors (data not shown). To alleviate this problem we adopted an extraction protocol in 95% ethanol that rapidly fixes the cells and greatly reduced BRCA1 degradation (see Materials and Methods). GAL-induced expression of BRCA1 protein was unaffected by deletion of the major transcriptional regulators that suppress lethality when compared to WT (Fig. 1D). Furthermore, intranuclear localization of GAL-induced BRCA1 was unaffected in suppressor mutants that regulate transcription (spt4Delta) or nuclear pore functions (nup170Delta) as determined by immunofluorescent detection (IF, Fig. 1E). Further, we "covered" three of the major suppressor deletion strains by expressing the SPT4, CTK1 and DEF1 genes. In each case, BRCA1 lethality was restored on GAL indicating that second site mutations were not responsible for the suppressor phenotype (Fig. 1F). Thus suppression of BRCA1 lethality appears to result from the identified gene deletions and absence of the corresponding gene products that functionally mediate the lethal BRCA1 response.
###end p 16
###begin title 17
Recombination and TCR repair are dispensable for BRCA1-induced lethality
###end title 17
###begin p 18
###xml 259 263 259 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Deng1">[14]</xref>
###xml 263 267 263 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Bau1">[15]</xref>
###xml 482 533 482 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e. rad50&#916;, rad51&#916;, rad52&#916;, rad55&#916;</italic>
###xml 538 547 522 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">xrs2&#916;</italic>
###xml 611 619 591 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001448.s001">Table S1</xref>
###xml 681 703 661 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rad54&#916;, rad57&#916;</italic>
###xml 707 717 679 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rdh54&#916;</italic>
###xml 750 754 718 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DEF1</italic>
###xml 754 758 722 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Woudstra1">[16]</xref>
###xml 763 767 731 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPT4</italic>
###xml 767 771 735 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Jansen1">[17]</xref>
###xml 866 946 834 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rad7&#916;, rad16&#916;, rad23&#916;, rad26&#916;, rad28&#916;, met18&#916;, rpb4&#916;</italic>
###xml 951 960 891 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rpb9&#916;</italic>
###xml 1145 1157 1081 1093 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAD16, MET18</italic>
###xml 1159 1163 1095 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RPB4</italic>
###xml 1165 1173 1101 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001448.s001">Table S1</xref>
###xml 1182 1186 1118 1122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAD7</italic>
###xml 1188 1207 1124 1143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAD23, RAD26, RAD28</italic>
###xml 1209 1213 1145 1149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RPB9</italic>
###xml 3 8 <span type="species:ncbi:9606">human</span>
###xml 212 217 <span type="species:ncbi:4932">yeast</span>
###xml 1116 1121 <span type="species:ncbi:4932">yeast</span>
###xml 1457 1462 <span type="species:ncbi:4932">yeast</span>
In human cells, BRCA1 has been shown to interact with components of the recombinational repair apparatus (Rad51p) as well as components of the non-homologous end-joining pathway which are all highly conserved in yeast and required for DSB repair (reviewed in [14][15]). We therefore examined strains individually deleted for members of the RAD52 epistasis group to determine if lethality was suppressed following GAL induced expression of BRCA1. Only some repair defective strains (i.e. rad50Delta, rad51Delta, rad52Delta, rad55Delta and xrs2Delta) demonstrated a modest suppression of BRCA1-induced lethality (Table S1). No suppression of BRCA1-induced lethality was observed for rad54Delta, rad57Delta or rdh54Delta strains (data not shown). Since DEF1[16] and SPT4[17] have been linked to transcription-coupled repair (TCR), we also examined a number of strains (rad7Delta, rad16Delta, rad23Delta, rad26Delta, rad28Delta, met18Delta, rpb4Delta and rpb9Delta) deleted for genes that have been implicated in TCR to determine if any were required for BRCA1-induced lethality. Following deletion of components of the yeast TCR apparatus, little (RAD16, MET18, RPB4; Table S1) or no (RAD7, RAD23, RAD26, RAD28, RPB9; data not shown) suppression of BRCA1-induced lethality was observed. These results suggest that recombination, non-homologous end-joining and TCR-mediated repair pathways are not responsible for the majority of the BRCA1-induced lethality in yeast.
###end p 18
###begin title 19
The DSIF complex is required for BRCA1-induced cell cycle arrest and the maintenance of genomic integrity following DNA damage
###end title 19
###begin p 20
###xml 53 54 53 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</italic>
###xml 98 99 98 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s</italic>
###xml 110 111 110 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</italic>
###xml 119 120 119 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</italic>
###xml 196 200 196 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Hartzog1">[18]</xref>
###xml 217 221 217 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Wada1">[19]</xref>
###xml 232 236 232 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPT5</italic>
###xml 355 359 355 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPT5</italic>
###xml 382 413 382 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">yml009w-b&#916;, yml009c-a&#916;,</italic>
###xml 413 421 405 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001448.s001">Table S1</xref>
###xml 437 449 429 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ygr064w&#916;</italic>
###xml 538 545 526 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g002">Fig. 2A</xref>
###xml 571 580 559 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dhh1&#916;</italic>
###xml 585 594 569 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ccr4&#916;</italic>
###xml 648 651 628 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Westmoreland1">[8]</xref>
###xml 651 655 631 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Westmoreland2">[12]</xref>
###xml 669 673 649 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPT4</italic>
###xml 741 748 721 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g002">Fig. 2B</xref>
###xml 809 816 789 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g002">Fig. 2C</xref>
###xml 847 851 827 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPT5</italic>
###xml 864 868 844 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Bennett1">[11]</xref>
###xml 980 989 960 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g002">Fig. 2D,E</xref>
###xml 1006 1015 986 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">spt4&#916;</italic>
###xml 1219 1226 1195 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g002">Fig. 2E</xref>
###xml 190 195 <span type="species:ncbi:4932">yeast</span>
###xml 205 210 <span type="species:ncbi:9606">human</span>
###xml 261 266 <span type="species:ncbi:4932">yeast</span>
###xml 766 771 <span type="species:ncbi:4932">yeast</span>
###xml 1190 1195 <span type="species:ncbi:4932">yeast</span>
###xml 1388 1393 <span type="species:ncbi:4932">yeast</span>
###xml 1496 1501 <span type="species:ncbi:4932">yeast</span>
Spt4p and Spt5p physically interact in the DSIF (5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole sensitivity inducing factor) complex with RNAPII to affect transcription elongation in both yeast [18] and human cells [19]. Although SPT5 is an essential gene in yeast, two overlapping ORFs from the deletion collection truncate the carboxy terminal end of SPT5 yet retain viability (yml009w-bDelta, yml009c-aDelta,Table S1). Furthermore, ygr064wDelta deletes the N terminus of Spt4p. These deletion strains all suppressed BRCA1 lethality (Fig. 2A) and similar to isogenic dhh1Delta and ccr4Delta strains, which have a checkpoint adaptation function [8][12], deletion of SPT4 suppressed the prolonged G1 arrest induced by expression of BRCA1 (Fig. 2B). DSIF defective yeast strains also exhibit IR sensitivity (Fig. 2C) previously described for the SPT5 truncations [11]. Furthermore DSIF defects resulted in enhanced sensitivity to the S phase specific damaging agents HU and MMS (Fig. 2D,E). Moreover, the spt4Delta allele resulted in enhanced chromosome instability, both spontaneously and following MMS exposure, when transferred into a strain that detects enhanced loss of a stable YAC (yeast artificial chromosome; Fig. 2E). These data indicate a shared role for the DSIF complex in DNA damage tolerance, maintenance of genomic stability and suppression of BRCA1-induced lethality in yeast. Taken together, these results suggest that BRCA1 subverts a conserved DNA damage response pathway in yeast in which DSIF plays a critical role.
###end p 20
###begin title 21
BRCA1 suppressor strains are sensitive to DNA damaging agents.
###end title 21
###begin p 22
###xml 77 89 77 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ygr064W&#916;</italic>
###xml 120 124 116 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPT4</italic>
###xml 150 154 146 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPT4</italic>
###xml 303 307 299 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPT5</italic>
###xml 376 390 372 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">yml009W-b&#916;</italic>
###xml 395 409 387 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">yml009c-a&#916;</italic>
###xml 459 463 447 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPT5</italic>
###xml 582 584 570 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 635 639 623 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPT4</italic>
###xml 994 998 982 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPT4</italic>
###xml 1150 1159 1138 1143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">spt4&#916;</italic>
###xml 1311 1320 1291 1296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">spt4&#916;</italic>
###xml 1325 1329 1301 1305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">spt5</italic>
###xml 1338 1352 1314 1324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">yml009w-b&#916;</italic>
###xml 1450 1454 1418 1422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Westmoreland2">[12]</xref>
###xml 1611 1620 1575 1580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">spt4&#916;</italic>
###xml 1625 1629 1585 1589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">spt5</italic>
###xml 1716 1725 1676 1681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ccr4&#916;</italic>
###xml 1733 1737 1689 1693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Westmoreland2">[12]</xref>
###xml 1824 1833 1780 1785 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">spt4&#916;</italic>
###xml 1916 1931 1868 1879 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">spt4&#916;, spt5</italic>
###xml 1943 1973 1891 1913 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">yml009w-b&#916;; yml009c-a&#916;</italic>
###xml 1979 1988 1919 1924 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ccr4&#916;</italic>
###xml 2026 2033 1962 1969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 2104 2113 2040 2045 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ccr4&#916;</italic>
###xml 2166 2170 2098 2102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPT4</italic>
###xml 2253 2262 2185 2190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">spt4&#916;</italic>
###xml 2323 2328 2251 2256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SUP11</italic>
###xml 2388 2396 2316 2324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ade2-101</italic>
###xml 2558 2567 2486 2491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">spt4&#916;</italic>
###xml 2825 2834 2749 2754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">spt4&#916;</italic>
###xml 3175 3184 3087 3096 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K. lactis</italic>
###xml 3209 3213 3121 3125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Westmoreland2">[12]</xref>
###xml 701 706 <span type="species:ncbi:4932">yeast</span>
###xml 1257 1262 <span type="species:ncbi:4932">yeast</span>
###xml 3175 3184 <span type="species:ncbi:28985">K. lactis</span>
(A) DSIF defective strains suppress BRCA1-induced lethality. Deletion of the ygr064WDelta ORF deletes the N terminus of SPT4. Full-length deletion of SPT4 also completely suppressed BRCA1 lethality. Spt4p physically interacts with Spt5p in the DSIF complex to confer transcription elongation functions. SPT5 is an essential gene, however the relative survival of two strains (yml009W-bDelta and yml009c-aDelta) containing non-lethal C terminal truncations of SPT5 was enhanced when compared to WT following BRCA1 expression. Relative colony forming ability for these strains on GAL vs GLU (GAL/GLU) has been indicated. (B) Deletion of SPT4 suppresses prolonged G1 arrest following BRCA1 expression in yeast. Individual unbudded (G1) cells were positioned using a micromanipulator into 4x5 cell grid patterns on GLU-URA and GAL-URA plates. None of the WT cells expressing BRCA1 (on GAL) were able to progress beyond the single cell (G1) stage of the cell cycle by 24 hours. However, deletion of SPT4 allowed most of the cells (13/20) to progress into microcolonies following BRCA1 expression. When BRCA1 was repressed (on GLU), most of the WT and the spt4Delta cells progressed beyond the G1 stage of the cell cycle to form microcolonies. (C) DSIF defective yeast strains are sensitive to gamma-irradiation. WT, spt4Delta and spt5 mutant (yml009w-bDelta) strains were grown to stationary phase and exposed to gamma-irradiation as previously described [12]. WT survival data was pooled with previous data (n = 10 experiments) to generate the gamma-ray WT survival curve depicted above. Survival fractions for the spt4Delta and spt5 strains are averaged from 3-4 experiments. Previously published survival data for the ccr4Delta strain [12] has been included for comparison. Error bars are +/- 1 SE about the mean. (D) Diploid spt4Delta strains are sensitive to the S phase specific DNA damaging agents HU and MMS. WT, spt4Delta, spt5 truncated (yml009w-bDelta; yml009c-aDelta) and ccr4Delta strains were exposed as described in Methods. Arrows indicate the direction of decreasing cell concentrations. The ccr4Delta strain has been included as a positive control. (E) SPT4 maintains chromosome stability following DNA damage. The WT (YPH656) and isogenic spt4Delta YPH656 derived strain contain a stable YAC that carries the SUP11 gene that allows read through of the ochre mutation within ade2-101. Strains that retain the YAC remain white while loss of the YAC results in a red colony. Strains were grown and diluted as described in Panel D. Two independent spt4Delta isolates demonstrate MMS hypersensitivity and enhanced MMS-induced chromosome loss as indicated by numerous (n = 10) red Ade- colonies (arrows) when compared to the WT parental YPH656 strain (no red colonies). Spontaneous YAC loss was observed in untreated spt4Delta strains. (F) BRCA1 suppressor strains are sensitive to gamma-irradiation and hypersensitive to zymocin. Strains were grown and diluted as described in Panel D. Diluted cells were replica spotted onto YPD and either left unirradiated (0 Dose), exposed to 80 krads of gamma-irradiation or plated to YPD containing zymocin toxin secreted from K. lactis as previously described [12].
###end p 22
###begin title 23
Other BRCA1-interactive targets mediate resistance to DNA damaging agents
###end title 23
###begin p 24
###xml 364 371 352 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g002">Fig. 2F</xref>
###xml 509 513 497 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Westmoreland2">[12]</xref>
###xml 726 731 <span type="species:ncbi:9606">human</span>
Many of the newly identified suppressors of BRCA1-induced lethality have not been previously associated with DNA damage sensitivity. Testing these strains, we found that most of the suppressor strains (11/17) demonstrated enhanced IR sensitivity (approximately5-10 fold) when compared to WT. Further, all of these strains were hypersensitive to the toxin zymocin (Fig. 2F) that arrests cells in the G1 phase of the cell cycle and affects a number of RNA metabolic processes including transcription elongation [12]. These results lend additional support for the biological relevance of this screen since we identified proteins involved in the maintenance of genomic integrity following DNA damage, a BRCA1-dependent process in human cells.
###end p 24
###begin title 25
###xml 27 32 <span type="species:ncbi:4932">yeast</span>
BRCA1-induced lethality in yeast is mediated by genome instability and plasmid loss
###end title 25
###begin p 26
###xml 334 341 334 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g003">Fig. 3A</xref>
###xml 1252 1259 1252 1259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g003">Fig. 3A</xref>
###xml 1316 1325 1316 1321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">spt4&#916;</italic>
###xml 1348 1355 1344 1351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g003">Fig. 3B</xref>
###xml 1480 1489 1476 1481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">spt4&#916;</italic>
###xml 1576 1585 1568 1573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">spt4&#916;</italic>
###xml 1665 1672 1653 1660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g003">Fig. 3C</xref>
###xml 26 31 <span type="species:ncbi:9606">human</span>
###xml 126 131 <span type="species:ncbi:4932">yeast</span>
###xml 225 230 <span type="species:ncbi:4932">yeast</span>
###xml 1773 1778 <span type="species:ncbi:4932">yeast</span>
Loss of BRCA1 function in human cells results in genome instability. We therefore investigated whether expression of BRCA1 in yeast was also genome-destabilizing and could account for some or all of the lethality observed in yeast. We first examined whether lethality was dependent on plasmid selection following expression of BRCA1 (Fig. 3A). In order to determine the kinetics of BRCA1-induced plasmid loss and subsequent lethality, we performed a "pullback" experiment in which WT cells containing the BRCA1 plasmid or empty vector were plated within GAL-URA or GAL+URA medium to induce BRCA1 expression. At increasing time intervals, we overlaid the GAL plates with either GLU-URA or GLU+URA medium to repress BRCA1 expression. When plasmid selection (-URA) was maintained throughout the experiment so that only plasmid retaining cells would survive, a rapid time dependent decrease in survival was observed. Following plating under non-selective conditions (+URA) survival was still significantly reduced as compared to WT cells containing empty vector, however survival was increased as compared to that under selective conditions indicating that loss of the plasmid selectable marker comprises only part of the observed BRCA1-induced lethality (Fig. 3A). We also directly analyzed plasmid loss in both WT and spt4Delta by Southern blotting (Fig. 3B). Supporting the growth result, dramatic plasmid loss is evident in WT. In contrast, the efficient suppressor of lethality, spt4Delta retained plasmid throughout the experiment. We also demonstrated plasmid retention in spt4Delta using a similar pullback approach following BRCA1 expression in liquid medium (Fig. 3C). Thus plasmid and chromosomal instability appears to play a key role in BRCA1-induced lethality in yeast.
###end p 26
###begin title 27
BRCA1-induced lethality involves plasmid loss and requires a functional BRCA1-BRCT domain.
###end title 27
###begin p 28
###xml 280 284 280 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">URA3</italic>
###xml 310 314 310 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Bennett2">[54]</xref>
###xml 632 636 632 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPT4</italic>
###xml 729 738 729 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">spt4&#916;</italic>
###xml 1016 1020 1012 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPT4</italic>
###xml 1147 1156 1143 1148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">spt4&#916;</italic>
###xml 1170 1174 1162 1166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPT4</italic>
###xml 1531 1535 1523 1527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">URA3</italic>
###xml 1828 1837 1820 1825 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">spt4&#916;</italic>
###xml 2210 2212 2198 2200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 2286 2293 2274 2281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g001">Fig. 1B</xref>
###xml 21 26 <span type="species:ncbi:4932">yeast</span>
###xml 2071 2076 <span type="species:ncbi:4932">yeast</span>
###xml 2346 2351 <span type="species:ncbi:4932">yeast</span>
(A) "Pullback" of WT yeast containing either the BRCA1 expression plasmid or empty vector control. To induce BRCA1, dilutions of plasmid bearing cells were plated into cooled liquid GAL agar containing medium with (+URA) or without (-URA) uracil selection for the plasmid marker (URA3) as previously described [54]. At the indicated times, BRCA1 expression was repressed by overlaying with GLU+URA or GLU-URA agar. For some data points, error bars (+/- 1 SD) are contained within the symbol. Enhanced lethality under selective conditions indicates plasmid loss is a significant component of BRCA1-induced lethality. (B) Deletion of SPT4 suppresses the physical loss of the BRCA1 expression plasmid. Stationary cultures of WT and spt4Delta strains containing the BRCA1 plasmid were "split" into twice the volume of GAL or GLU to express or repress BRCA1 respectively. Expression of BRCA1 in WT cells (in GAL) resulted in a time dependent increase in plasmid loss as determined by Southern analysis. Cells deleted for SPT4 retain the BRCA1 plasmid following BRCA1 expression. When BRCA1 was repressed, plasmid was physically retained in both WT and spt4Delta strains. (C) SPT4 deletion suppresses plasmid loss following BRCA1 expression. The viability of cells from the experiment described in Panel B was determined by plating aliquots at the indicated times onto YPD agar medium and genetically determining plasmid loss by replica plating the resulting colonies onto GLU-URA plates to detect the presence or absence of the plasmid URA3 marker (URA+). The relative survival of colony forming ability following repression (in GLU; left panel, two experiments) or induction of BRCA1 (in GAL; right panel, four experiments) in liquid media is shown. A significant loss of the plasmid marker can be observed in the WT but not in the spt4Delta strain following BRCA1 expression. No significant loss of the BRCA1 plasmid can be seen for either strain when the cells were grown in GLU. (D) Breast cancer associated mutations within the BRCT domain of BRCA1 suppress lethality in yeast. A single base pair was mutated within the BRCA1 expression plasmid (I1766S). The relative survival of colony forming ability on GAL vs GLU (GAL/GLU survival, four experiments) was determined as described for Fig. 1B. Complete suppression of BRCA1-induced lethality in yeast was also observed following deletion of the C-terminal 10 amino acids of BRCA1 that also disrupts BRCT domain function (data not shown).
###end p 28
###begin title 29
###xml 27 32 <span type="species:ncbi:4932">yeast</span>
BRCA1-induced lethality in yeast requires the BRCT domain
###end title 29
###begin p 30
###xml 52 55 52 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Humphrey1">[7]</xref>
###xml 104 108 104 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Coyne1">[20]</xref>
###xml 194 199 194 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 691 698 691 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g003">Fig. 3D</xref>
###xml 3 8 <span type="species:ncbi:4932">yeast</span>
###xml 188 193 <span type="species:ncbi:4932">yeast</span>
###xml 654 659 <span type="species:ncbi:4932">yeast</span>
###xml 834 839 <span type="species:ncbi:4932">yeast</span>
###xml 947 952 <span type="species:ncbi:4932">yeast</span>
###xml 1109 1114 <span type="species:ncbi:4932">yeast</span>
In yeast, slow growth following expression of BRCA1 [7] was shown to be associated with the BRCT domain [20]. We separately introduced two breast cancer associated BRCT mutations into the yeast BRCA1 expression plasmid. In one construct, we introduced a single nucleotide change that resulted in a BRCT amino acid substitution (I1766S). For the second mutation, we introduced a premature stop codon that truncated the BRCA1 protein by deleting the last 10 C-terminal amino acids. Following GAL induction, both mutant proteins were expressed in amounts similar to that observed for the full-length WT BRCA1. Neither of these mutant BRCA1 proteins reduced yeast survival following expression (Fig. 3D; data not shown). To extend this observation, we cloned the final 333 amino acids of BRCA1 containing the tandem BRCT domains into the yeast high copy expression plasmid pDEST52. Similar to full-length BRCA1, expression of the BRCT construct in WT yeast resulted in significant but slightly reduced lethality (relative survival fraction = 0.21+/-0.06; +/-1 SE). Thus, the majority of the lethality observed in yeast following expression of full-length BRCA1 appears to be mediated through the BRCT domain.
###end p 30
###begin title 31
###xml 8 12 8 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTK1</italic>
###xml 64 69 <span type="species:ncbi:4932">yeast</span>
CTDK-I (CTK1 kinase) is required for BRCA1-induced lethality in yeast
###end title 31
###begin p 32
###xml 225 229 225 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Moisan1">[21]</xref>
###xml 448 453 448 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SRB10</italic>
###xml 457 461 457 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BUR2</italic>
###xml 548 552 548 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTK1</italic>
###xml 592 600 592 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001448.s001">Table S1</xref>
###xml 602 609 602 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g001">Fig. 1C</xref>
###xml 661 665 661 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTK1</italic>
###xml 836 840 836 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Jones1">[22]</xref>
###xml 840 844 840 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Phatnani1">[23]</xref>
A critical and unique feature of elongating RNAPII is its hyperphosphorylated and highly conserved CTD domain. The identity of several suppressor strains as well as the ability of BRCA1 to modulate RNAPII CTD phosphorylation [21] suggested a connection between BRCA1 and transcription elongation by RNAPII. We therefore tested whether deleting genes in subunits of three different CTD kinases could suppress BRCA1 lethality. We found that deleting SRB10 or BUR2, had only a modest impact on the suppression of BRCA1 lethality. Remarkably, deleting CTK1 completely suppressed BRCA1 lethality (Table S1, Fig. 1C). This result argues that BRCA1 lethality requires CTK1-dependent phosphorylation of the RNAPII CTD, and suggests that the molecular mechanism of BRCA1 lethality requires the pattern of CTD phosphorylation specified by CTDK-I [22][23].
###end p 32
###begin title 33
BRCA1 genetically interacts with the CTD of RNAPII
###end title 33
###begin p 34
###xml 183 187 183 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Jona1">[24]</xref>
###xml 480 484 477 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAL1</italic>
###xml 713 720 707 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 979 986 973 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g004">Fig. 4A</xref>
###xml 1127 1131 1121 1125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">URA3</italic>
###xml 235 240 <span type="species:ncbi:4932">yeast</span>
###xml 338 343 <span type="species:ncbi:4932">yeast</span>
###xml 748 753 <span type="species:ncbi:4932">yeast</span>
Since the DSIF complex and the Ctk1p suppressor kinase interact with the elongating form of RNAPII and the regulatory CTD domain of Rpb1p plays a key role in transcription elongation [24], we investigated whether overexpression of the yeast RNAPII CTD could influence BRCA1 lethality. To do this we constructed a C-terminal fusion of the yeast RNAPII CTD to beta-galactosidase with and without a nuclear localization signal (NLS). These constructs were inserted into a selectable GAL1 expression vector and following expression of these fusion protein constructs, the beta-galactosidase-CTD fusion was found predominantly in the cytoplasm (cyto-CTD; no NLS) or in the nucleus (nuc-CTD; with NLS) as determined by in situ IF (data not shown). In WT yeast that concomitantly express BRCA1 from a second selectable plasmid, expression of the cyto-CTD significantly suppressed BRCA1-induced lethality whereas expression of the nuc-CTD significantly augmented the lethality of BRCA1 (Fig. 4A). Part of this augmented BRCA1-induced lethality appears to be directed towards enhanced nuc-CTD plasmid instability as addition of uracil (URA3 is the selectable marker for the CTD expression plasmids) to the GAL plates decreased the lethal effects of co-expressing BRCA1 and the RNAP II CTD in the nucleus. Thus RNAPII CTD co-expression significantly altered the degree of BRCA1 lethality and indicated a genetic interaction between BRCA1 and the expressed RNAPII CTD.
###end p 34
###begin title 35
BRCA1 interacts with the phosphorylated RNAPII CTD to induce cleavage and proteasome-mediated degradation.
###end title 35
###begin p 36
###xml 278 282 278 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HIS3</italic>
###xml 284 289 284 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAL::</italic>
###xml 415 417 415 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 453 460 453 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g001">Fig. 1B</xref>
###xml 1109 1117 1109 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in trans</italic>
###xml 2167 2171 2167 2171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DEF1</italic>
###xml 2218 2227 2218 2223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">def1&#916;</italic>
###xml 2583 2592 2579 2584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">def1&#916;</italic>
###xml 2689 2693 2681 2685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTK1</italic>
###xml 2740 2749 2732 2737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ctk1&#916;</italic>
###xml 2987 2996 2975 2980 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ctk1&#916;</italic>
###xml 3159 3163 3143 3147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ERG6</italic>
###xml 3292 3301 3276 3281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">erg6&#916;</italic>
###xml 58 63 <span type="species:ncbi:4932">yeast</span>
###xml 68 73 <span type="species:ncbi:4932">yeast</span>
###xml 1231 1236 <span type="species:ncbi:4932">yeast</span>
###xml 1602 1607 <span type="species:ncbi:4932">yeast</span>
###xml 3140 3145 <span type="species:ncbi:4932">yeast</span>
###xml 3220 3225 <span type="species:ncbi:4932">yeast</span>
(A) BRCA1 genetically interacts with the RNAPII CTD in WT yeast. WT yeast cells were transformed with plasmids that express the RNAPII CTD in the nucleus (nuc-polII CTD) or cytoplasm (cyto-polII CTD) due to the presence or absence of a NLS signal sequence. A second selectable (HIS3) GAL::BRCA1 expression vector was subsequently established in these strains by transformation. Relative plating efficiencies on GAL vs GLU was determined as described in Fig. 1B with plasmid selection. Co-expression of the BRCA1 and the cyto-CTD construct significantly (*) suppressed BRCA1-induced lethality, whereas co-expression of BRCA1 and the nuc-CTD construct significantly (*) augmented lethality. The relative survival fraction for cells containing both the BRCA1 and nuc-CTD plasmids was less than (<) 0.08 since no colonies appeared on the GAL-HIS-URA plates. This augmented lethality could be partially "relieved" by plating cells to non-selective medium where retention of the nuc-CTD construct was not required for viability (in medium containing uracil; +URA). This indicated that nuc-CTD plasmid loss occurred in trans following BRCA1 expression. Error bars are the average of 4-6 experiments (+/- 1 SD). (B) BRCA1 expression in WT yeast induces cleavage of the RNAPII CTD. Following BRCA1 expression in WT cells, Western blots were probed with anti-2,5P CTD antibody (anti-2,5P, upper panel), stripped and re-probed with anti-BRCA1 antibody (lower panel). The positions of the intact phosphorylated RNAPII (IIo) and a novel BRCA1-induced 50 kDa phospho-CTD (P-CTD) fragment have been indicated. (C) WT yeast that express BRCA1 with a BRCT domain defect fail to induce P-CTD cleavage. WT cells containing BRCA1, BRCT mutated (I1766S) or empty plasmid expression vectors were induced for BRCA1 expression in GAL and extracted at the times indicated. Western blots utilized anti-2,5P CTD (upper panel) and anti-BRCA1 (middle panel) antibodies as probes. Anti-Act1p antibody (bottom panel) served as a loading control. P-CTD cleavage in cells containing the empty vector was identical to that seen for the BRCT mutant expression plasmid (data not shown). (D) Deletion of DEF1 inhibits BRCA1-induced P-CTD cleavage. WT and def1Delta strains containing the BRCA1 plasmid were induced for BRCA1 expression and extracted at the indicated times. Anti-2,5P CTD (upper panel) and anti-BRCA1 (middle panel) antibodies were utilized as Western blot probes. Pgk1p served as a loading control unaffected by the switch from GLU to GAL (bottom panel). The P-CTD fragment is greatly diminished in the def1Delta strain when compared to an equivalently loaded WT induced for BRCA1 expression. (E) Deletion of CTK1 inhibits BRCA1-induced P-CTD cleavage. WT and ctk1Delta strains containing the BRCA1 plasmid were induced for BRCA1 expression and extracted at the indicated times. Cells were extracted, proteins separated and Western blotted as described in C above. The P-CTD fragment is undetectable in the ctk1Delta strain using either anti-2,5P or H14 anti-5 P antibody (data not shown). (F) MG132 inhibits degradation of the BRCA1-induced P-CTD fragment in yeast. Deletion of ERG6 facilitates uptake of the proteasome inhibitor MG132 in yeast. We therefore established the BRCA1 expression plasmid within the erg6Delta strain and induced BRCA1 expression in the absence (left panels) and presence of MG132 (right panels). Persistence of the P-CTD fragment is enhanced by MG132 treatment indicating that the P-CTD fragment is targeted for proteasome-mediated degradation.
###end p 36
###begin title 37
###xml 20 25 <span type="species:ncbi:4932">yeast</span>
BRCA1 expression in yeast results in cleavage of the RNA polymerase II P-CTD
###end title 37
###begin p 38
###xml 360 364 360 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTK1</italic>
###xml 373 377 373 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Jones1">[22]</xref>
###xml 377 381 377 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Phatnani2">[25]</xref>
###xml 601 608 601 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g004">Fig. 4B</xref>
###xml 1037 1044 1025 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g004">Fig. 4B</xref>
###xml 1220 1227 1208 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g004">Fig. 4C</xref>
###xml 1333 1337 1321 1325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DEF1</italic>
###xml 1344 1351 1332 1339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g004">Fig. 4D</xref>
###xml 1471 1475 1459 1463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Reid1">[13]</xref>
###xml 1568 1577 1556 1561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ctk1&#916;</italic>
###xml 1682 1689 1666 1673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g004">Fig. 4E</xref>
###xml 1832 1841 1816 1821 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">erg6&#916;</italic>
###xml 1942 1949 1922 1929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g004">Fig. 4F</xref>
###xml 2116 2118 2096 2098 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 2184 2193 2164 2173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001448.s001">Figure S1</xref>
###xml 136 141 <span type="species:ncbi:4932">yeast</span>
###xml 2290 2295 <span type="species:ncbi:4932">yeast</span>
Given the genetic connections between BRCA1 lethality and the Rpb1p CTD, we examined the status of RNAPII following BRCA1 expression in yeast, employing a polyclonal antibody raised and purified against a synthetic CTD repeat peptide phosphorylated on every Ser2 and Ser5 residue (anti-2,5P), the pattern of phosphorylation preferentially generated by CTDK-I (CTK1 kinase, [22][25]). Unexpectedly, the predominant band observed in Western blots of extracts from cells expressing BRCA1 was not the intact, hyperphosphorylated Rpb1p subunit (IIo), but a band with an electrophoretic mobility of 50 kDa (Fig. 4B). This 50 kDa species appears to represent the P-CTD, cleaved from the rest of the Rpb1p subunit (the N-terminal fragment would not be detected by the anti-2,5P antibody). Its mobility is what might be expected for a segment of Rpb1p containing the entire hyperphosphorylated CTD plus an additional approximately100 amino acids N-terminal to the CTD. The appearance of this P-CTD fragment depends on the expression of WT BRCA1 (Fig. 4B) since it was observed in only very limited amount after expression of the two disease associated BRCA1 mutants or after galactose induction of cells containing empty vector (Fig. 4C; data not shown). BRCA1-induced accumulation of the P-CTD fragment also was found to be dependent on the DEF1 gene (Fig. 4D) whose product has been implicated in ubiquitin-mediated proteasomal degradation of RNAPII stalled following UV damage [13]. Furthermore, BRCA1-induced accumulation of the P-CTD fragment was similarly reduced in the ctk1Delta strain even though BRCA1 was expressed at levels comparable to that observed in the isogenic WT strain (Fig. 4E). BRCA1-induced accumulation of the P-CTD fragment was enhanced by concomitant treatment with the proteasome inhibitor MG132 in the permeable erg6Delta strain suggesting that the P-CTD was subject to proteasome-mediated degradation following cleavage (Fig. 4F). To confirm the identity of the 50 kDa species, we were able to detect this band after BRCA1 expression in strains that express an Rpb1p allele with a C-terminal His10 tag or a reduced number of heptapeptide repeat units in the CTD (Figure S1). Taken together, these results indicate that expression of BRCA1 with an intact BRCT domain in yeast leads to the appearance of a novel P-CTD fragment, cleaved from a form of RNAPII whose phosphorylation state is dependent on CTDK-I. Subsequent stability of this fragment is influenced by the proteasome system.
###end p 38
###begin title 39
###xml 41 46 <span type="species:ncbi:4932">yeast</span>
###xml 51 56 <span type="species:ncbi:9606">human</span>
BRCA1 interacts with the DSIF complex in yeast and human cells
###end title 39
###begin p 40
###xml 42 51 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">spt4&#916;</italic>
###xml 56 60 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">spt5</italic>
###xml 380 387 376 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g005">Fig. 5A</xref>
###xml 784 793 780 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g005">Fig. 5B,C</xref>
###xml 824 825 820 821 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 845 852 841 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g005">Fig. 5B</xref>
###xml 1267 1274 1263 1270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g005">Fig. 5C</xref>
###xml 1442 1449 1438 1445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g005">Fig. 5C</xref>
###xml 61 66 <span type="species:ncbi:4932">yeast</span>
###xml 246 251 <span type="species:ncbi:4932">yeast</span>
###xml 256 261 <span type="species:ncbi:9606">human</span>
###xml 314 319 <span type="species:ncbi:4932">yeast</span>
###xml 415 420 <span type="species:ncbi:4932">yeast</span>
Suppression of BRCA1-induced lethality in spt4Delta and spt5 yeast strains suggests that the DSIF complex may mediate interaction of BRCA1 with RNAPII. Therefore, we tested whether components of the DSIF complex physically interact with BRCA1 in yeast and human cells. Following expression of a V5 tagged Spt4p in yeast co-expressing BRCA1, we were able to co-IP BRCA1 and Spt4p (Fig. 5A). As our genetic screen in yeast was intended to identify novel BRCA1 interactive targets in mammalian cells, we turned our attention to a more physiologically relevant system. Using lysates from the MCF7 breast cancer cell line that harbors wild type BRCA1, we detected an interaction between endogenous SPT5 and BRCA1 by co-IP analysis. This interaction was present both in unirradiated cells (Fig. 5B,C) and in cells following 20 J/m2 of UV-irradiation (Fig. 5B). In HCC1937 cells harboring a hemizygous BRCA1 mutation (5382insC resulting in mistranslation starting at codon 1755 and premature termination at 1829), we found no detectable interaction between these two proteins, with or without DNA damage suggesting that the BRCA1 C-terminal domain is required. In MCF7 cells the interaction was detectable in both directions using either SPT5 or BRCA1 as a capture protein (Fig. 5C, right half). Finally, interactions between SPT5, BRCA1 and the phosphorylated full-length form of RPB1 (IIo) were also detectable in unirradiated MCF7 cell extracts (Fig. 5C, left half).
###end p 40
###begin title 41
BRCA1-DSIF complexes are rapidly degraded.
###end title 41
###begin p 42
###xml 73 78 73 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAL::</italic>
###xml 88 93 88 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAL::</italic>
###xml 101 105 101 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LEU2</italic>
###xml 1125 1126 1125 1126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 45 50 <span type="species:ncbi:4932">yeast</span>
###xml 380 385 <span type="species:ncbi:10090">mouse</span>
###xml 1038 1043 <span type="species:ncbi:9606">human</span>
###xml 1258 1263 <span type="species:ncbi:10090">mouse</span>
###xml 1299 1304 <span type="species:ncbi:10090">mouse</span>
###xml 1910 1915 <span type="species:ncbi:9606">human</span>
###xml 2005 2010 <span type="species:ncbi:10090">mouse</span>
(A) Spt4p physically interacts with BRCA1 in yeast. WT cells bearing the GAL::BRCA1 and GAL::Spt4-V5-LEU2 expression plasmids were induced for co-expression of BRCA1 and Spt4-V5 (16 hrs). Whole cell lysates (WCL) were prepared in various concentrations of NP40 and either loaded directly (200 ug/lane) or subjected to co-IP reactions overnight using anti-BRCA1 antibody or normal mouse IgG. Proteins were separated by SDS-PAGE and subjected to Western blotting using anti-V5 antibody as a probe. Spt4p is detected as a double band in WCL of WT cells migrating between 14 and 20 kDa. This doublet Spt4p band was also detected endogenously using anti-Spt4p antibody (sc-26353, Santa Cruz) as a probe (data not shown). The upper Spt4-V5 band was observed to interact maximally with BRCA1 at an NP40 concentration of 0.8%. BRCA1 similarly interacted with endogenous Spt4p when anti-Spt4p antibody (sc-26353, Santa Cruz) was used as the IP antibody (data not shown). (B) Interaction of BRCA1 with SPT5 is dependent on the BRCA1-BRCT domain in human cells. MCF7 and HCC1937 cells were either left untreated or exposed to UV (20 J/m2) for 6hr in the presence of the proteasome inhibitor MG132 (50 uM). WCL were prepared and subjected to co-IP analysis using normal mouse IgG (NLM), anti-BRCA1 or anti-SPT5 mouse monoclonal antibody as the IP reagent. Western immunoblot (IB) analysis utilized anti-BRCA1 as a probe. The interaction of SPT5 with BRCA1 is observed in both unirradiated and UV-irradiated MCF7 cells. Interaction between BRCA1, and SPT5 is abolished in HCC1937 cells. At the time of irradiation, cells were treated with the proteasome inhibitor MG132 (50 uM) to inhibit rapid damage-induced degradation of the BRCA1-SPT5 complex. In the absence of proteasome inhibition, no BRCA1-SPT5 interaction was seen following UV irradiation (data not shown). (C) BRCA1 interacts with SPT5 and RNA polymerase II in human cells. Co-IP reactions using the indicated monoclonal antibodies and normal (non-immune) mouse IgG (NLM) were separated by SDS-PAGE. Western immunoblot (IB) analysis utilized, anti-BRCA1, anti-2,5P and anti-SPT5 as probes. Both BRCA1 and SPT5 interacted with the full-length hyperphosphorylated form of RNA polymerase II (IIo). SPT5 interaction with BRCA1 could be detected using either anti-BRCA1 or anti-SPT5 monoclonal antibodies as the immunoprecipitation reagent. Interaction between SPT5 and BRCA1 was abolished in HCC1937 cells that express a BRCT defective form of BRCA1. (D) Rapid MMS-induced degradation of BRCA1, SPT5 and RNAPII is BRCT domain dependent. MCF and HCC1937 cells were either left unexposed or exposed to the radiomimetic methyl methanesulfonate (MMS) for 2 hours at 37degreesC. Separated proteins were Western immunoblotted using anti-BRCA1, anti-SPT5, anti-RNAPII antibody N20 and anti-actin as probes. Whereas MMS treatment of MCF7 cells (BRCA1+/+) led to a dramatic degradation of BRCA1, SPT5 and RNAPII (Rpb1 subunit). MMS treatment of HCC1937 cells (BRCA1-/-) resulted in reduced and/or delayed degradation of the three proteins. These results suggest that the co-degradation may be a BRCT domain dependent process.
###end p 42
###begin title 43
MMS treatment induces rapid degradation of BRCA1, SPT5 and RPB1
###end title 43
###begin p 44
###xml 130 134 130 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Starita1">[26]</xref>
###xml 134 138 134 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Kleiman1">[27]</xref>
###xml 513 520 513 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g005">Fig. 5D</xref>
BRCA1 appears to have ubiquitin ligase activity, with phosphorylated RPB1 acting as a substrate in a DNA damage responsive manner [26][27] . Since SPT5 appears to be associated with both BRCA1 and the RNA polymerase, we asked whether its degradation was influenced by BRCA1 or DNA damage. Treatment of MCF7 and HCC1937 cells with the radiomimetic alkylating agent MMS for 2h induced a dramatic dose dependent decrease in steady-state SPT5 levels in the BRCA1 wild type MCF7 cells but not the mutant HCC1937 line (Fig. 5D). Loss of BRCA1 and RPB1 was also much more dramatic in MCF7 cells providing further evidence for a functional link between these proteins. Proteasome inhibition only partially prevented the damage-induced loss of all three proteins in MCF7 cells (data not shown). Dependence of damage-induced degradation of BRCA1, SPT5 and RPB1 on a functional BRCA1-BRCT domain suggests that this BRCA1-mediated degradation pathway may be critical for the suppression of tumorigenesis. Moreover, the BRCA1-mediated co-degradative loss of the abundant SPT5 protein along with RNA polymerase II suggests that the DSIF complex may have a key role in maintaining RNAPII stability prior to DNA damage.
###end p 44
###begin title 45
###xml 50 55 <span type="species:ncbi:4932">yeast</span>
###xml 60 65 <span type="species:ncbi:9606">human</span>
P-CTD cleavage is induced following DNA damage in yeast and human cells
###end title 45
###begin p 46
###xml 290 291 290 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 381 388 381 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g006">Fig. 6A</xref>
###xml 79 84 <span type="species:ncbi:4932">yeast</span>
###xml 231 236 <span type="species:ncbi:4932">yeast</span>
Since BRCA1 may subvert a conserved transcription associated damage pathway in yeast to exert its lethal effects, we examined if UV-irradiation, an efficient block to transcriptional elongation, could also induce P-CTD cleavage in yeast. Following a moderate dose of UV irradiation (120 J/m2), a transient 50 kDa P-CTD fragment was detected between 4 and 5 hours post irradiation (Fig. 6A).
###end p 46
###begin title 47
###xml 44 49 <span type="species:ncbi:4932">yeast</span>
###xml 54 59 <span type="species:ncbi:9606">human</span>
DNA damage induces RNAPII P-CTD cleavage in yeast and human cells.
###end title 47
###begin p 48
###xml 122 123 122 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 689 690 689 690 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1740 1741 1728 1729 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 2900 2904 2852 2856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Elstrodt1">[57]</xref>
###xml 3843 3847 3787 3791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Starita1">[26]</xref>
###xml 17 22 <span type="species:ncbi:4932">yeast</span>
###xml 82 87 <span type="species:ncbi:4932">yeast</span>
###xml 1603 1608 <span type="species:ncbi:9606">human</span>
###xml 1616 1621 <span type="species:ncbi:9606">Human</span>
###xml 2277 2282 <span type="species:ncbi:9606">human</span>
###xml 2456 2461 <span type="species:ncbi:4932">yeast</span>
###xml 4295 4300 <span type="species:ncbi:4932">yeast</span>
###xml 4440 4445 <span type="species:ncbi:4932">yeast</span>
###xml 4618 4623 <span type="species:ncbi:4932">yeast</span>
(A) UV damage in yeast induces RNAPII P-CTD cleavage. Stationary phase WT diploid yeast cells were irradiated with 120 J/m2 of UV-irradiation. UV induced a transient 50 kDa RNAPII P-CTD cleavage fragment at 4-5 hours following irradiation and outgrowth in fresh YPD medium. This fragment was similar in size to that observed following BRCA1 expression. The survival fraction for colony forming ability following UV irradiation was 0.70. P-CTD cleavage was not observed in unirradiated control cells (data not shown). (B) Antibodies specific for the RNAPII CTD immunoprecipitate a RNAPII P-CTD fragment following UV irradiation. WCL were prepared from unirradiated and UV-irradiated (20 J/m2) MCF7 and T47D cells 4 hours after irradiation in the presence of MG132 and subsequently immunoprecipitated with either 2,5P or 8WG16 anti-CTD antibodies. 8WG16 is specific for unphosphorylated and partially phosphorylated forms of Rpb1. Immunoprecipitates were separated on polyacrylamide gels and the P-CTD detected by Western blot using the 2,5P anti-CTD antibody as described above. UV damage enhanced the ability to detect the P-CTD fragment by immunoblotting following immunoprecipitation (IP) with either 2,5P or 8WG16 antibody. Although P-CTD fragment was detected in extracts from unirradiated cells, the ability to IP the P-CTD fragment was enhanced in extracts from UV-irradiated cells. Images depict proteins greater than 75 kDa. Cross-reacting heavy chain antibodies used in the IP reactions were detected at approximately50 kDa (data not shown). (C) UV-irradiation induces RNAPII P-CTD cleavage in human cells. Human cell lines MCF7 and HCC1937 were grown to 70-80% confluence and either left unirradiated or irradiated with UV (20 J/m2). Unirradiated (-) and UV-irradiated (+) cells were subsequently incubated at 37degreesC in growth medium with (+) or without (-) the proteasome inhibitor MG132 for 6 hours. Whole cell lysates were prepared by scraping cells into 95% ethanol at 4degreesC. Proteins extracted in the ethanol soluble fraction were separated on a 4-15% polyacrylamide gel and probed with anti-2,5P antibody. Following initial immunoblotting, the membrane was stripped and re-probed with anti-actin antibody to serve as a loading control. Since the CTD of human RNAPII contains 52 heptapeptide repeat units, UV-induced the cleavage of Rpb1 releasing a P-CTD fragment that was approximately twice the size (approximately110 kDa) of the yeast P-CTD fragment which contains 25 heptapeptide repeats (approximately50 kDa, see panel A). In repeated experiments, the P-CTD fragment was frequently observed in extracts from unirradiated MG132 treated cells (data not shown) however, detection of the P-CTD fragment was enhanced in extracts from similarly treated cells exposed to UV. Greatly reduced levels of P-CTD cleavage was also observed in the BRCA1 defective cell line MDA-MD-436 [57] following UV-irradiation and proteasome inhibition (data not shown). (D) UV-induced RNAPII P-CTD cleavage is BRCA1-dependent. Cells with a BRCA1-BRCT domain defect (HCC1937) were separately transfected with empty vector (PC) or vectors expressing truncated BRCA1 (BRCA1-DeltaM) and full-length wild type BRCA1. At 48 hours post transfection cells were UV-irradiated, treated with MG132 and homogenized in ethanol as described above (panel C) and methods. Aliquots (10 ul) from the insoluble fraction resuspended in loading buffer were separated by SDS-PAGE and immunoblotted (IB) with the indicated antibodies as described above (panel C). The P-CTD cleavage fragment was only observed following ectopic expression of full-length wild type BRCA1. The faster mobility of the BRCA1 protein expressed from the BRCA1-DeltaM construct is due to an in frame internal deletion of 518 amino acids which retains the RING and BRCT domains of BRCA1 [26]. BRCA1 expressed endogenously in the HCC1937 cells is detected as a lighter band with mobility similar to that of the ectopically overexpressed BRCA1. (E) A model for BRCA1 DNA damage surveillance during transcription. This model describes a BRCA1-dependent transcription-mediated checkpoint/surveillance system that is highly conserved among eukaryotes. The components of this pathway were identified as suppressors of BRCA1-induced lethality in yeast. Following DNA damage within actively transcribing genes, the elongating phosphorylated RNA pol II (form IIo) is stalled by DNA damage. In yeast, the Ctk1p kinase specifies the phosphorylation pattern of the CTD "recognized" by BRCA1. BRCA1 in the presence of specific co-factors including DSIF (Spt4p/Spt5p) and the yeast degradation factor Def1p is proposed to bind the P-CTD. This activates a protease activity that cleaves the CTD from the catalytic domain of Rpb1p (resulting in CTD-less form IIb). We propose this event is an upsteam signal that activates checkpoint arrest in G1. The checkpoint arrest signal remains "on" until prematurely terminated mRNA is exported from the nucleus utilizing Mlp1p, Mlp2p and numerous nuclear pore components to be degraded at the cytoplasmic processing body utilizing Ccr4p and Dhh1p. Following P-CTD cleavage, Rpb1p is targeted for ubiquitin-mediated degradation at the proteasome.
###end p 48
###begin p 49
###xml 407 414 395 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g006">Fig. 6B</xref>
###xml 762 769 750 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g006">Fig. 6B</xref>
###xml 859 866 847 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g006">Fig. 6B</xref>
###xml 1126 1133 1114 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g006">Fig. 6B</xref>
###xml 1356 1363 1344 1351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g004">Fig. 4F</xref>
###xml 45 50 <span type="species:ncbi:4932">yeast</span>
###xml 55 60 <span type="species:ncbi:9606">human</span>
###xml 92 97 <span type="species:ncbi:9606">human</span>
###xml 143 148 <span type="species:ncbi:4932">yeast</span>
###xml 216 221 <span type="species:ncbi:9606">human</span>
###xml 1326 1331 <span type="species:ncbi:4932">yeast</span>
Although the repeated RNAPII CTD sequence of yeast and human cells is highly conserved, the human CTD is approximately twice the length of the yeast CTD. Consistent with this larger size, following UV-irradiation of human breast epithelial cells and immunoprecipitation with the 2,5P antibody, we detected the appearance of a approximately110 kDa P-CTD cleavage fragment in MCF7 and T47D (BRCA1 +/+) cells (Fig. 6B). To confirm the identity of this CTD fragment, we used comparative immunoprecipitations with 2,5P and a second anti-CTD specific antibody 8WG16, which recognizes both unphosphorylated as well as partially phosphorylated RNAPII CTDs. These anti-CTD antibodies detected the 110 kDa CTD fragment in both of the BRCA1 (+/+) cell lines MCF7 and T47D (Fig. 6B). Interestingly, the P-CTD fragment can be observed in extracts from unirradiated cells (Fig. 6B) suggesting that P-CTD cleavage may result from RNAPII pausing and/or spontaneous damage during ongoing transcription. Since treatment with the proteasome inhibitor MG132 was required to detect increased levels of the UV-induced P-CTD fragment in MCF7 cells (Fig. 6B), this suggests that the P-CTD fragment is targeted by ubiquitination for rapid proteasome degradation following cleavage. Persistence of the P-CTD fragment was also enhanced in MG132 treated yeast cells expressing BRCA1 (Fig. 4F). These results suggest that damage-induced P-CTD cleavage is a conserved eukaryotic response.
###end p 49
###begin title 50
Damage-induced P-CTD cleavage is a BRCA1-dependent response
###end title 50
###begin p 51
###xml 200 207 200 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g006">Fig. 6C</xref>
###xml 373 380 373 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g006">Fig. 6C</xref>
###xml 925 932 921 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g006">Fig. 6D</xref>
###xml 1062 1066 1054 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Starita1">[26]</xref>
###xml 1167 1174 1159 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g006">Fig. 6D</xref>
###xml 1506 1515 1486 1495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001448.s002">Figure S2</xref>
###xml 1665 1670 <span type="species:ncbi:9606">human</span>
To determine if P-CTD cleavage was a BRCA1-dependent damage response, we UV-irradiated BRCA1 (+/+) and BRCA1 (-/-) breast epithelial cells with and without exposure to the proteasome inhibitor MG132 (Fig. 6C). RNAPII P-CTD cleavage was observed in UV-irradiated BRCA1 (+/+) cells (MCF7) but not in BRCA1 (-/-) breast cancer cells (HCC1937) following proteasome inhibition (Fig. 6C). Since treatment with MG132 was required to visualize the UV-induced P-CTD fragment in BRCA1 (+/+) cells, the P-CTD is likely eliminated rapidly via the proteasome pathway. To confirm that UV-induced P-CTD cleavage was a BRCA1-dependent process, we ectopically expressed either full-length (wild type) or an internal deletion (DeltaM) BRCA1 construct in the BRCA1 mutant cell line HCC1937. Following UV-irradiation and proteasome inhibition with MG132, the P-CTD fragment was only detected in cells expressing the full-length wild type BRCA1 (Fig. 6D). Expression of the truncated BRCA1 construct (DeltaM) containing an in frame internal deletion spanning amino acids 775 to 1203 [26] in HCC1937 cells did not support P-CTD cleavage following UV-irradiation and proteasome inhibition (Fig. 6D). Furthermore, using the N20 antibody that recognizes the N terminus of RPB1, we clearly visualized the reciprocal approximately180 kDa RPB1 IIb cleavage product (a fragment that cannot be detected with the anti-2,5P antibody) that arises following loss of the P-CTD after DNA damage in HCC1937 cells that express wild type BRCA1 (Figure S2). Taken together, these results demonstrate that UV-induced P-CTD cleavage is mechanistically linked to expression of the wild type BRCA1 protein in human breast epithelial cells.
###end p 51
###begin title 52
Discussion
###end title 52
###begin p 53
###xml 970 977 970 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g006">Fig. 6E</xref>
###xml 1135 1139 1135 1139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR4</italic>
###xml 1144 1148 1144 1148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DHH1</italic>
###xml 1218 1222 1218 1222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAD9</italic>
###xml 1303 1307 1303 1307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Westmoreland2">[12]</xref>
###xml 1334 1338 1334 1338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR4</italic>
###xml 1343 1347 1343 1347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DHH1</italic>
###xml 1402 1406 1402 1406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Bergkessel1">[28]</xref>
###xml 1406 1410 1406 1410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Traven1">[29]</xref>
###xml 1410 1414 1410 1414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Mulder1">[30]</xref>
###xml 1414 1418 1414 1418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Woolstencroft1">[31]</xref>
###xml 1516 1520 1516 1520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Fabbro1">[32]</xref>
###xml 1608 1612 1608 1612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Starita1">[26]</xref>
###xml 122 128 <span type="species:ncbi:9606">humans</span>
###xml 133 138 <span type="species:ncbi:4932">yeast</span>
###xml 238 243 <span type="species:ncbi:4932">yeast</span>
###xml 305 310 <span type="species:ncbi:4932">yeast</span>
###xml 412 417 <span type="species:ncbi:4932">yeast</span>
###xml 428 433 <span type="species:ncbi:9606">human</span>
###xml 1570 1575 <span type="species:ncbi:9606">human</span>
In trying to define a fundamental role for BRCA1 in breast cancer, we took advantage of the evolutionary distance between humans and yeast to identify proteins and/or processes that have the ability to interact functionally with BRCA1 in yeast; these BRCA1-interacting partners were identified by finding yeast deletions that suppress BRCA1-induced lethality. For such "targets" to be biologically relevant, the yeast genes and human orthologs would most likely play roles in DNA damage responses and genome stability, and they would have an increased likelihood to physically interact with the BRCA1 protein. We present evidence that fulfills these criteria for proteins in the DSIF complex (SPT4/SPT5). Further, DSIF and other conserved suppressors of BRCA1-induced lethality may be grouped into a temporally linked mRNA signaling/decay pathway that responds to DNA damage encountered by RNAPII in actively transcribing genes at the elongation stage of transcription (Fig. 6E). Specifically, we identified BRCA1 suppressors that participate in mRNA transcription elongation as well as mRNA export and decay. Some of the suppressors (CCR4 and DHH1) were first identified and characterized as IR resistance genes in a RAD9-dependent, checkpoint pathway required for G1/S transition following DNA damage [12]. This checkpoint role for CCR4 and DHH1 has been subsequently confirmed by other laboratories [28][29][30][31] and a role for BRCA1 in G1/S checkpoint arrest following IR damage has been previously described [32]. Similarly, following overexpression of BRCA1 in human cells, a G1 arrest was observed [26].
###end p 53
###begin p 54
###xml 464 468 464 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Scully1">[33]</xref>
###xml 468 472 468 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Anderson1">[34]</xref>
###xml 8 13 <span type="species:ncbi:4932">yeast</span>
###xml 451 456 <span type="species:ncbi:9606">human</span>
###xml 530 535 <span type="species:ncbi:4932">yeast</span>
The two yeast genes whose deletion most potently suppressed BRCA1-induced G1 arrest and lethality were those of the conserved transcription elongation factor Spt4p and the elongation phase-specific CTD kinase I (Ctk1-kinase), underlying the critical role that transcription elongation and RNAPII CTD phosphorylation play in BRCA1-mediated lethality. Furthermore, in agreement with previously described physical interactions observed between BRCA1 and human RNAPII [33][34], BRCA1 was found to interact with the P-CTD of RNAPII in yeast resulting in P-CTD cleavage. It should be noted that the ethanol procedure used to prevent BRCA1 degradation extracts a relatively small fraction of the total cellular protein. Therefore, the amount of RNAPII that undergoes cleavage is unclear at this time.
###end p 54
###begin p 55
###xml 312 321 312 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">def1&#916;</italic>
###xml 426 430 422 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Reid1">[13]</xref>
###xml 108 113 <span type="species:ncbi:4932">yeast</span>
###xml 635 640 <span type="species:ncbi:9606">human</span>
###xml 663 668 <span type="species:ncbi:9606">human</span>
Disease-associated mutations in BRCA1 that are expressed in this system neither reduce the viability of the yeast nor result in P-CTD cleavage suggesting that these events may be causally linked. Further support for the association of P-CTD cleavage and lethality comes from the rescue of both phenotypes in the def1Delta strain, previously shown to be defective for ubiquitin-mediated RNAPII degradation following DNA damage [13]. These results implicate BRCA1 in DNA damage-mediated degradation of elongating RNAPII via cleavage of the P-CTD. The highly conserved nature of the Rpb1p CTD suggested that similar interactions occur in human cells. Our results in human breast cancer cell lines fully support this interpretation. We have shown that P-CTD fragments exist in breast cancer cell lines, are stabilized by proteasome inhibition, and depend upon the presence of wild type BRCA1. Reconstitution of the damage-induced P-CTD accumulation following ectopic expression of wild type BRCA1 in the mutant HCC1937 cell line provides direct evidence for this process.
###end p 55
###begin p 56
###xml 599 603 591 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Starita1">[26]</xref>
###xml 764 768 752 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Starita1">[26]</xref>
###xml 35 40 <span type="species:ncbi:4932">yeast</span>
###xml 90 95 <span type="species:ncbi:9606">human</span>
###xml 258 263 <span type="species:ncbi:4932">yeast</span>
Results from ectopic expression in yeast of mutant BRCA1 proteins and from examination of human HCC1937 cells (expressing a carboxy terminal BRCA1 deletion) both point to the BRCT domain of BRCA1 as the mediator of P-CTD cleavage and associated lethality in yeast. Although the BRCA1-BRCT domain is necessary to promote P-CTD cleavage, it is not sufficient. For example, the BRCA1(DeltaM) construct (that contains intact RING and BRCT domains) fails to reconstitute BRCA1-induced P-CTD cleavage following DNA damage. Furthermore, the BRCA1-DeltaM construct can promote ubiquitination of intact RPB1 [26], suggesting that P-CTD cleavage and ubiquitination are separate processes. Moreover, the relative ease in transiently overexpressing the BRCA1-DeltaM construct [26] compared to the wild type may be related to this defect in P-CTD cleavage.
###end p 56
###begin p 57
###xml 159 167 159 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 167 171 167 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Starita1">[26]</xref>
###xml 171 175 171 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Kleiman1">[27]</xref>
###xml 189 193 189 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DEF1</italic>
###xml 348 357 348 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">def1&#916;</italic>
###xml 364 368 360 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Reid1">[13]</xref>
###xml 607 611 603 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Gillette1">[35]</xref>
###xml 358 363 <span type="species:ncbi:4932">yeast</span>
###xml 481 486 <span type="species:ncbi:4932">yeast</span>
A critical role for BRCA1 and its stochiometric binding partner BARD1 in ubiquitin-mediated degradation of phosphorylated RNAPII has been previously described in vitro[26][27]. Deletion of DEF1 inhibits BRCA1-mediated RNAPII CTD cleavage and degradation much in the same manner as ubiquitin targeted RNAPII degradation is inhibited following UV in def1Delta yeast [13]. This suggests that BRCA1 subverts a conserved RNAPII degradation response to DNA damage to induce lethality in yeast. Following DNA damage, Def1p may be essential to couple arrested RNAPII to the proteasome to facilitate its degradation [35].
###end p 57
###begin p 58
###xml 76 80 76 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Krum1">[36]</xref>
###xml 80 84 80 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Kleiman1">[27]</xref>
###xml 84 88 84 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Starita1">[26]</xref>
###xml 147 151 147 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Moisan1">[21]</xref>
###xml 207 211 207 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTK1</italic>
###xml 379 382 379 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e</italic>
###xml 482 486 482 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Manke1">[37]</xref>
###xml 636 640 636 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTK1</italic>
###xml 644 652 644 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001448.s001">Table S1</xref>
###xml 846 850 846 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Krum1">[36]</xref>
###xml 1216 1220 1216 1220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Jeong1">[38]</xref>
###xml 1220 1224 1220 1224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Somesh1">[39]</xref>
###xml 1254 1258 1254 1258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Starita1">[26]</xref>
###xml 1258 1262 1258 1262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Kleiman1">[27]</xref>
###xml 1498 1502 1498 1502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Choudhury1">[40]</xref>
###xml 1744 1751 1744 1751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g006">Fig. 6B</xref>
###xml 604 609 <span type="species:ncbi:9606">human</span>
###xml 1209 1214 <span type="species:ncbi:4932">yeast</span>
###xml 1242 1247 <span type="species:ncbi:9606">human</span>
BRCA1 associates preferentially with the hyperphosphorylated form of RNAPII [36][27][26] and appears to modulate RNAPII CTD phosphorylation levels [21]. Our finding that loss of the CTD specific kinase gene CTK1 completely suppresses BRCA1-induced lethality indicates that BRCA1 interacts preferentially with the phosphorylated elongating form of the RNAPII specified by CTDK-I (i.e. phosphorylated on Ser2 and Ser5). The preferential interaction of BRCT domains with phosphoserine [37] suggests a potential physical interaction between BRCA1 and the P-CTD and predicts a critical role for the conserved human Ctk1p ortholog CRKRS (see CTK1 in Table S1). Others have reported that, upon treatment with DNA damaging agents, the association of BRCA1 with RNAPII was disrupted suggesting a link between DNA damage signaling/repair and transcription [36]. The apparent damage-induced disruption of BRCA1 interaction with RNAPII may reflect degradation of RNAPII following DNA damage, dependent on specific co-factors such as DSIF as suggested in this study. The finding of enhanced phosphorylation and subsequent proteasome-mediated degradation of RNAPII that involves P-CTD cleavage following DNA damage in both yeast ([38][39] (this study) and human cells [26][27] (this study) further illustrates the important conserved role these ubiquitin-mediated degradation processes play in the BRCA1 damage response. Moreover, the finding that proteasome mediated degradation of BRCA1 occurs primarily in G1 [40] supports a spontaneous role for BRCA1 in degrading RNAPII in the absence of damage. Alternatively, spontaneous damage within transcriptionally active genes may account for the P-CTD cleavage observed in unirradiated breast epithelial cells (Fig. 6B).
###end p 58
###begin p 59
###xml 71 75 71 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Ye1">[41]</xref>
###xml 214 218 214 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Yamaguchi1">[42]</xref>
###xml 451 458 451 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g006">Fig. 6E</xref>
###xml 592 596 592 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Ljungman1">[43]</xref>
###xml 596 600 596 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-LindseyBoltz1">[44]</xref>
###xml 856 860 856 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Aiyar1">[45]</xref>
###xml 1138 1145 1138 1145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g006">Fig. 6E</xref>
###xml 1479 1483 1479 1483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Sheth1">[46]</xref>
###xml 1483 1487 1483 1487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Cougot1">[47]</xref>
###xml 1624 1631 1624 1631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g006">Fig. 6E</xref>
###xml 1929 1933 1929 1933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Abbott1">[48]</xref>
###xml 1933 1937 1933 1937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-LePage1">[49]</xref>
###xml 2069 2073 2069 2073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Guo1">[50]</xref>
###xml 483 488 <span type="species:ncbi:9606">human</span>
###xml 1169 1174 <span type="species:ncbi:9606">human</span>
###xml 1381 1386 <span type="species:ncbi:9606">human</span>
Interaction of BRCA1 with the negative elongation factor NELF-B/COBRA1 [41] combined with the finding that COBRA1, which, as part of the NELF complex interacts with DSIF to negatively regulate RNAPII transcription [42] is fully supportive of our determination that the DSIF complex also interacts genetically and physically with BRCA1 and suggests a damage signaling role for both COBRA1 and DSIF in concert with BRCA1 and RNAPII. Our study supports (Fig. 6E) an emerging model that human cells employ the RNAPII holoenzyme complex during transcription elongation for DNA damage surveillance [43][44] . In this respect, BRCA1 may act as a sensor of DNA damage to monitor stalling of the transcription apparatus at DNA lesions and, therefore, participates in a transcriptional checkpoint to signal the presence of lesions within actively transcribing genes [45]. As suggested by this study, a G1 checkpoint arrest signal might be maintained until subsequent transport of the prematurely terminated transcript for degradation at P-bodies and disassembly of the RNAPII-BRCA1-DSIF complex by ubiquitin-mediated degradation at the proteasome (Fig. 6E). Our finding that the human ortholog of Dhh1p (DDX6) interacts with BRCA1 in the cytoplasm at P-bodies following DNA damage also supports such a model (T. Westmoreland and J. Marks, unpublished). The determination that Dhh1p (and its human ortholog, DDX6) is an essential component of processing bodies that are sites of mRNA decay [46][47] allows us to functionally link transcription elongation arrest by DNA damage to mRNA export and decay through BRCA1 and P-CTD cleavage (Fig. 6E). Thus BRCA1 may facilitate repair of DNA damage by mediating P-CTD cleavage and subsequent degradation of stalled transcription complexes to allow enhanced access of repair complexes to the lesion site. This model also accommodates reports that BRCA1 participates in transcription-coupled repair [48][49] and is supported by the finding that overexpression of hTREX84 and dysregulation of mRNA export may be a hallmark of breast tumors [50]. Taken together our data support BRCA1 playing a critical role in a novel checkpoint pathway that senses DNA damage within actively transcribed DNA to initiate cleavage and degradation of stalled RNAPII elongation complexes. Furthermore, our results showing BRCA1-BRCT function is required for the rapid alkylation-induced degradation of BRCA1-SPT5 and RNAPII suggests that chemotherapeutic treatments utilizing alkylating agents may be clinically effective for treating breast cancers in which BRCA1-mediated degradation is defective. Moreover, the use of proteasome inhibitors in concert with alkylating agents may be equally effective for treating those breast cancers in which the damage-induced BRCA1-SPT5-RNAPII degradation pathway remains intact. Defects in this conserved BRCA1-dependent RNAPII cleavage and degradation pathway may be critical for the initiation of breast or ovarian cancer, predicting that genetic defects in other conserved components of this pathway may also contribute to these diseases.
###end p 59
###begin title 60
Materials and Methods
###end title 60
###begin title 61
Strain and plasmid constructs
###end title 61
###begin p 62
###xml 328 332 328 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Basrai1">[51]</xref>
###xml 334 338 334 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPT4</italic>
###xml 394 410 394 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">spt4&#916;::KanMX</italic>
###xml 425 434 421 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">spt4&#916;</italic>
###xml 696 712 688 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">spt4&#916;::KanMX</italic>
###xml 806 816 794 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001448.s004">Methods S1</xref>
Unless otherwise stated, WT and deletion strains are in the diploid BY4743 strain background. The strains, primers and technique utilized for deletion strain construction have been described (www-sequence.stanford.edu/group/yeast_deletion_project/deletions3.html). The YPH656 YAC containing strain has been previously described [51]. SPT4 was deleted in the YPH656 strain by PCR amplifying the spt4Delta::KanMX loci from the spt4Delta strain in the BY4743 strain background obtained from the diploid deletion strain collection (Open Biosystems, Huntsville, AL) using forward (5'-GCG GTC CTC GTA GTC CAA TTT ACG TG-3') and reverse (5' GCC TTA GTT GAA TTA CTG GAC GGT AG-3') primers that flank the spt4Delta::KanMX deletion sites. Further details of strain and plasmid constructions are in the supplementary Methods S1.
###end p 62
###begin title 63
Genome-wide screen for suppressors of BRCA1-induced lethality
###end title 63
###begin p 64
###xml 410 411 400 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 521 524 507 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Westmoreland1">[8]</xref>
###xml 537 541 523 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">URA3</italic>
###xml 553 556 539 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAL</italic>
###xml 1408 1412 1384 1388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Winzeler1">[52]</xref>
###xml 1686 1688 1662 1664 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 148 153 <span type="species:ncbi:4932">Yeast</span>
###xml 570 575 <span type="species:ncbi:4932">yeast</span>
A pool of 4746 nonessential diploid deletion strains each containing a unique 20 base pair genetic tag was obtained from Invitrogen (Carlsbad, CA). Yeast deletion strains were thawed from a frozen aliquot of the pooled strains (200 microl, at room temperature) and grown by inoculating the thawed cells into a 50 ml volume of YPD liquid medium maintained at 30degreesC with shaking until a cell count of 1-2x107 cells/ml was obtained. Cells were made competent and transformed with 1-2 microg of the previously described [8] selectable (URA3) high copy GAL::BRCA1 YEp24 yeast BRCA1 expression plasmid (BRCA1 plasmid). Following transformation, cells were plated directly to synthetic complete (SC) galactose containing medium (2%) lacking uracil (GAL). Rapidly growing colonies were picked following 2-4 days incubation at 30degreesC. Individual colonies were streak purified on GAL plates. Individual colonies were tested for the ability to suppress BRCA1-induced lethality by growing WT and mutant strains containing the BRCA1 plasmid in liquid SC glucose containing medium (2%) lacking uracil (GLU) until stationary phase was reached in 96 well dishes. Stationary phase cultures were serially diluted (5 fold) in sterile water and 2 microl aliquots were replica plated to GLU and GAL solid medium. Isolates that showed enhanced survival on GAL plates when compared to WT were processed for identification [52]. To confirm that the identified deletions were true suppressors of BRCA1-induced lethality, we reestablished the BRCA1 plasmid into the individual deletion strains from the arrayed diploid deletion strain collection (Open Biosystems) and confirmed enhanced survival on GAL vs GLU.
###end p 64
###begin title 65
Suppression of BRCA1-induced G1 arrest and lethality
###end title 65
###begin p 66
###xml 72 92 72 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">spt4&#916;, def1&#916;</italic>
###xml 97 106 89 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ctk1&#916;</italic>
###xml 183 184 171 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
To examine suppression of the BRCA1-induced checkpoint delay at G1, WT, spt4Delta, def1Delta and ctk1Delta strains containing the BRCA1 plasmid were grown to logarithmic phase (1-2x107 cells/ml) in liquid GLU medium. Single unbudded (G1) cells were micromanipulated into a 4x5 grid pattern of cells onto solid GLU and GAL plates using a Singer MSM 300 dissecting microscope (Singer Instrument Co., Somerset, UK) and photographed hourly.
###end p 66
###begin title 67
###xml 52 57 <span type="species:ncbi:4932">yeast</span>
Western analysis of BRCA1 and RNAPII extracted from yeast or breast epithelial cells
###end title 67
###begin p 68
###xml 219 223 219 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Lee1">[53]</xref>
###xml 1171 1175 1165 1169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Lee1">[53]</xref>
###xml 1352 1356 1346 1350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Phatnani2">[25]</xref>
###xml 67 72 <span type="species:ncbi:4932">yeast</span>
###xml 1037 1043 <span type="species:ncbi:9986">rabbit</span>
To minimize degradation of BRCA1 and RNAPII during extraction from yeast, cell pellets from 50 ml of growth cultures were homogenized by bead beating in 0.7 ml of 95% ice cold ethanol on dry ice as previously described [53] with the following modifications. Cells were lysed by bead beating for 45 second pulses (6x) at maximum velocity in a Fastprep FP120 bead beater (Q-biogene, Irvine, CA). Lysates were allowed to cool at 4degreesC for 5 minutes between pulses. Insoluble material was pelleted and the resulting supernatant transferred to a new microfuge tube and evaporated to dryness under low heat in a rotary evaporator. Dried protein samples were resuspended in 2x SDS-PAGE loading buffer without tracking dye. Protein concentrations were determined using the NanoOrange detection kit (Invitrogen) before addition of tracking dye and separation by SDS-PAGE. Separated proteins were electroblotted to nitrocellulose and probed with antibodies against the hyperphosphorylated CTD of RNAPII largest subunit ["anti-2,5P": is from a rabbit antiserum that was raised against a CTD fusion protein exhaustively phosphorylated by CTDK-I; IgGs were affinity purified (see [53]), first using the phosphorylated fusion protein and next using a synthetic CTD 3-repeat peptide phosphorylated on every Ser2 and Ser5 of the heptapeptide repeats (Ser2,5P; see [25])]. Anti-Act1p (sc-1615, Santa Cruz, Santa Cruz, CA) or anti-Pgk1p (anti-PGK 22C5, Invitrogen) were used as loading control probes. Following detection of RNAPII, blots were stripped and reprobed for BRCA1 (MS110, EMD Chemicals, San Diego, CA).
###end p 68
###begin p 69
###xml 111 112 111 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 486 487 483 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
For mammalian cells, RNAPII was extracted by scraping cells directly into ice cold 95% ethanol (0.5 ml per 5x106 cells). Cells were freeze-thawed three times and insoluble material was pelleted. The supernatant fluid was evaporated to dryness in a rotary evaporator and the resulting protein pellet resuspended in 2x loading buffer with beta-mercaptoethanol. Alternatively, the pellet of ethanol insoluble material was resuspended in a large volume of 2x loading buffer (300 ul per 5x106 cells). Aliquots (10-30 ul) were separated, electroblotted, and probed as described above.
###end p 69
###begin title 70
###xml 12 17 <span type="species:ncbi:4932">yeast</span>
Exposure of yeast and mammalian cells to DNA damaging agents
###end title 70
###begin p 71
###xml 358 362 348 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Westmoreland2">[12]</xref>
###xml 664 668 640 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Westmoreland2">[12]</xref>
###xml 1086 1087 1062 1063 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1118 1119 1094 1095 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1238 1239 1202 1203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1270 1271 1234 1235 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1351 1352 1315 1316 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 14 19 <span type="species:ncbi:4932">yeast</span>
WT and mutant yeast strains were grown to stationary phase at 30degrees (2 days) in 200 microl of YPD liquid medium in 96 well dishes. The cells were serially diluted in YPD (5 fold) and replica plated to YPD plates alone or YPD plates containing 0.02%-0.03% methyl methanesulfonate (MMS), 200mM hydroxyurea (HU) or 66% crude zymocin as previously described [12]. Cells plated to YPD alone were left unexposed or irradiated with 80 krads of gamma-irradiation at a dose rate of 2.38 krads/min. Cells were continually exposed to HU, MMS or zymocin, by incubating the plates for 2-3 days at 30degrees. gamma-ray survival curves were generated as previously described [12]. For UV-irradiation, WT diploid cells were grown to stationary phase as described above in 80 ml of YPD liquid medium. Unirradiated cells, (5 ml) were concentrated into a pellet by centrifugation and the supernatant fluid discarded. The cell pellet was flash frozen and stored as described above. A 40 ml volume of the remaining cell suspension was concentrated into a pellet by centrifugation, washed 1x in sterile H2O and resuspended in 15 ml of H2O. Cells were UV-irradiated in a sterile 100 mm Petri dish with constant agitation at a dose rate of approximately1 J/m2/sec to a total dose of 120 J/m2 using a germicidal lamp. Following irradiation cells were diluted to 40 ml in H2O and mixed with 40 ml of 2x liquid YPD. Cells were incubated at 30degreesC with vigorous agitation and 10 ml aliquots were concentrated by centrifugation, the supernatant was discarded and the resulting pellet was flash frozen at hourly intervals. Frozen cell pellets were extracted on dry ice in 0.4 ml 95% ethanol as described above. Extracted protein samples were resuspended in 50 ul of 2x loading buffer and 20 ul volumes separated on Tris-HCL gels as described above. RNAPII CTD cleavage was detected using anti-2,5P (P-CTD) antibody. Unirradiated and UV-irradiated cells were diluted in sterile water and plated to YPD plates to determine the relative survival of colony forming ability following UV-irradiation.
###end p 71
###begin p 72
###xml 242 243 230 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 17 22 <span type="species:ncbi:9606">human</span>
###xml 131 137 <span type="species:ncbi:9913">bovine</span>
###xml 433 438 <span type="species:ncbi:9606">human</span>
MCF7 and HCC1937 human breast cancer cell lines were grown to approximately80% confluence in RPMI 1640 medium containing 10% fetal bovine serum. Medium was removed from the cell monolayers and either left unirradiated or UV-irradiated (20 J/m2) using a UV Stratalinker 1800 (Stratagene, La Jolla, CA). Cells were refed with fresh medium with or without MG132 for 4-6 hours and whole cell lysates (WCL) prepared. For MMS treatment of human cells, MMS was placed in fresh complete RPMI medium and cells were incubated for 2 hours at 37degreesC.
###end p 72
###begin title 73
###xml 53 58 <span type="species:ncbi:4932">yeast</span>
Southern blot analysis of BRCA1 plasmid stability in yeast
###end title 73
###begin p 74
###xml 7 16 7 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">spt4&#916;</italic>
###xml 117 121 113 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Bennett2">[54]</xref>
###xml 355 359 351 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Bennett2">[54]</xref>
WT and spt4Delta strains containing the BRCA1 plasmid were grown to stationary phase and total genomic DNA extracted [54]. Equal aliquots of extracted DNA were separated on a 0.7% agarose gel, transferred to a nylon membrane by Southern blotting using a positive pressure apparatus (Stratagene) and immobilized by UV cross-linking as previously described [54]. The BRCA1 plasmid was labeled and visualized on the membrane following hybridization using the non-radioactive AlkPhos Direct labeling and detection kit (Amersham Biosciences, Piscataway, NJ).
###end p 74
###begin title 75
###xml 25 30 <span type="species:ncbi:4932">yeast</span>
Proteasome inhibition in yeast and mammalian cells using MG132
###end title 75
###begin p 76
###xml 4 13 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">erg6&#916;</italic>
###xml 21 25 17 21 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Lee2">[55]</xref>
###xml 297 298 289 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
The erg6Delta strain [55] in the BY4743 background containing the BRCA1 plasmid was induced for BRCA1 expression in GAL as described above. At 6 hours following GAL induction, cells were treated with 50 microM MG132 or vehicle (DMSO). Undamaged MCF7 or HCC1937 cells or those exposed to UV (20 J/m2) were concomitantly treated with MG132 (dissolved in DMSO) resuspended in complete RPMI medium to a final concentration of 50 microM.
###end p 76
###begin title 77
Co-immunoprecipitation
###end title 77
###begin p 78
###xml 11 16 <span type="species:ncbi:4932">yeast</span>
###xml 558 563 <span type="species:ncbi:10090">mouse</span>
###xml 772 777 <span type="species:ncbi:10090">mouse</span>
To prepare yeast WCL, cells were concentrated by centrifugation and residual growth medium discarded. Cell pellets were resuspended in 0.5 ml of ice cold NP40 buffer (0.05-0.1% NP40, 50 mM Tris pH 8.0, 5 mM EDTA, 150 mM NaCl) plus protease inhibitors and lysed by bead beating for 45 second pulses at maximum velocity in a Fastprep FP120 bead beater (Q-biogene, Irvine, CA). Lysates were allowed to cool at 4degreesC for 5 minutes between pulses. WCL were precleared by centrifugation followed by incubation of the supernatant for 24 hrs at 4degreesC normal mouse IgG (Vector Laboratories, Burlingame, CA) plus a 1:1 mixture of Protein A and G beads (Roche Diagnostics, Nutley, NJ). For co-IP interactions, precleared lysate was reacted overnight at 4degreesC with normal mouse IgG, anti-V5 (Invitrogen) or anti-BRCA1 antibody (MS110) plus Protein A and/or G agarose. IP reactions were washed 2-3x in NP40 buffer with protease inhibitors. Following the last wash, SDS-PAGE loading buffer was added to the beads and heated at 95degreesC for 5 minutes prior to SDS-PAGE.
###end p 78
###begin p 79
###xml 226 231 <span type="species:ncbi:10090">mouse</span>
For breast cancer cell lines, culture monolayers were gently washed 3x in ice cold PBS and lysed with gentle shaking at 4degreesC in 0.5 ml of NP40 buffer (0.08% NP40) plus protease inhibitors. WCL were precleared with normal mouse IgG and subjected to co-IP analysis as described above using anti-RNAPII CTD antibody, anti-BRCA1 antibody (MS110), or anti-SPT5 antibody (anti-DSIF 61107, BD Biosciences, San Jose, CA). For detection on Western blots; N20 (sc-899, Santa Cruz) or anti-2,5P were used as probes.
###end p 79
###begin title 80
###xml 40 45 <span type="species:ncbi:4932">yeast</span>
Immunofluorescent detection of BRCA1 in yeast
###end title 80
###begin p 81
###xml 77 81 77 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001448-Pringle1">[56]</xref>
###xml 25 30 <span type="species:ncbi:4932">yeast</span>
###xml 673 677 <span type="species:ncbi:9925">goat</span>
###xml 871 875 <span type="species:ncbi:9925">goat</span>
###xml 881 886 <span type="species:ncbi:10090">mouse</span>
IF detection of BRCA1 in yeast was adapted from previously described methods [56]. Briefly, after BRCA1 expression was induced by shaking for six hours at 30degreesC in GAL, cells were fixed in formaldehyde for 1 hr at RT, recovered by centrifugation, resuspended in 50 mM phosphate-buffered formaldehyde plus sorbitol (1.2M) and fixed a further two hours at RT. After Zymolyase treatment (1 mg/ml Zymolyase 100T ICN) for 30 min at 37degreesC, cells were washed and stored at 4degreesC for antibody staining. For BRCA1 detection, cells were placed onto polylysine-coated slides. The cells were fixed again at -20degreesC in methanol and acetone and then blocked (5% normal goat serum, 1% glycerol, 0.1% BSA, 0.1% fish skin gelatin in sterile PBS) for 30 minutes. The primary antibody (MS1101 microg/ml) was reacted for 2 hrs at RT, followed by incubation for 1 hr with a goat anti-mouse IgG conjugated with Alexflour 488 (Jackson Immunoresearch Laboratories, West Grove, PA). Hoechst 33342 diluted 1:10,000 in PBS was added 5 minutes before coverslipping.
###end p 81
###begin title 82
Supporting Information
###end title 82
###begin p 83
###xml 18 23 <span type="species:ncbi:4932">yeast</span>
Identification of yeast diploid deletion strains that suppress lethality following heterologous expression of the tumor suppressor BRCA1.
###end p 83
###begin p 84
(0.15 MB DOC)
###end p 84
###begin p 85
Click here for additional data file.
###end p 85
###begin p 86
###xml 146 151 <span type="species:ncbi:4932">yeast</span>
###xml 281 286 <span type="species:ncbi:4932">yeast</span>
###xml 734 739 <span type="species:ncbi:4932">yeast</span>
Characterization of the BRCA1-induced P-CTD fragment. The 50 kDa BRCA1-induced fragment detected by anti 2,5P is specific for the RNAPII CTD. The yeast strain CTD-His10a expresses an Rpb1p allele with an in frame C-terminal His10 tag fused to the Rpb1p CTD (left panels). The 12AR yeast strain expresses Rpb1p with a truncated CTD containing 12 heptapeptide repeats. These strains were induced for BRCA1 expression and extracted in ethanol as described above. For the CTD-His10a strain, Western blots were probed with anti-2,5P P-CTD antibody (upper panels), stripped and reprobed with anti-His antibody (Amersham, lower panel). The anti-His antibody detects the 50 kDa fragment previously detected by the anti-2,5P CTD antibody. The yeast strain expressing a truncated RNAPII CTD (12AR) exhibited a smaller P-CTD fragment when compared to the BRCA1-induced fragment from the WT strain containing the full-length Rpb1p CTD using the anti-2,5P antibody as a probe. Lower panel is a longer exposure of the upper panel.
###end p 86
###begin p 87
(7.72 MB TIF)
###end p 87
###begin p 88
Click here for additional data file.
###end p 88
###begin p 89
###xml 230 237 230 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">methods</xref>
###xml 242 249 242 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g006">Fig. 6D</xref>
###xml 307 308 307 308 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 427 434 427 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g006">Fig. 6D</xref>
###xml 622 629 622 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g006">Fig. 6D</xref>
###xml 983 990 971 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001448-g006">Fig. 6D</xref>
###xml 80 85 <span type="species:ncbi:9606">Human</span>
DNA damage induces BRCA1-dependent cleavage of RPB1 in breast epithelial cells. Human breast epithelial cells that are mutant for BRCA1 (HCC1937) were transfected with PC control, BRCA1-delta M and wild-type BRCA1 as described in methods and Fig. 6D. Following transfection, cells were UV-irradiated (20 J/m2) and treated with the proteasome inhibitor MG132 for 6 hours. Sample aliquotes (30 ul) identical to that described in Fig. 6D were separated by SDS-PAGE and transferred to nitrocellulose. The Western blot was probed with the N20 antibody specific for the N terminus of RPB1. Following initial immunoblotting (see Fig. 6D), stripped membranes were reprobed with anti-actin antibody to serve as a loading control. The majority of full-length RPB1was converted from the hypophosphorylated from of RPB1 (IIa) to the hyperphosphorylated form of Rpb1 (IIo). UV damage induced a BRCA1-dependent cleavage of RPB1 into the IIb form (approximately180 kDa) and the P-CTD fragment (see Fig. 6D) that is not detected by the N20 antibody.
###end p 89
###begin p 90
(3.75 MB TIF)
###end p 90
###begin p 91
Click here for additional data file.
###end p 91
###begin p 92
(0.05 MB DOC)
###end p 92
###begin p 93
Click here for additional data file.
###end p 93
###begin p 94
The authors would like to thank R. Randell, J. Knupp, C. Mohr, A. Chatterjee and T. Wijesekera for expert technical help with some of the experiments. We would like to thank Drs. N. Chiba, H. Fried, T. Hsieh, M. Resnick, J. Stiller, M. Tyers and F. Winston for the gift of plasmids and strains.
###end p 94
###begin title 95
References
###end title 95
###begin article-title 96
Cancer susceptibility and the functions of BRCA1 and BRCA2.
###end article-title 96
###begin article-title 97
BRCA1 facilitates microhomology-mediated end joining of DNA double strand breaks.
###end article-title 97
###begin article-title 98
BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures.
###end article-title 98
###begin article-title 99
Redistribution of BRCA1 among four different protein complexes following replication blockage.
###end article-title 99
###begin article-title 100
Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes.
###end article-title 100
###begin article-title 101
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast as an honorary mammal.
###end article-title 101
###begin article-title 102
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 31 36 <span type="species:ncbi:4932">yeast</span>
Human BRCA1 inhibits growth in yeast: potential use in diagnostic testing.
###end article-title 102
###begin article-title 103
###xml 79 84 <span type="species:ncbi:4932">yeast</span>
Dhh1 regulates the G1/S-checkpoint following DNA damage or BRCA1 expression in yeast.
###end article-title 103
###begin article-title 104
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alpha-synuclein.
###end article-title 104
###begin article-title 105
###xml 20 25 <span type="species:ncbi:4932">yeast</span>
A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease.
###end article-title 105
###begin article-title 106
###xml 52 57 <span type="species:ncbi:4932">yeast</span>
Genes required for ionizing radiation resistance in yeast.
###end article-title 106
###begin article-title 107
###xml 114 138 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Cell cycle progression in G1 and S phases is CCR4 dependent following ionizing radiation or replication stress in Saccharomyces cerevisiae.
###end article-title 107
###begin article-title 108
DNA damage-induced Def1-RNA polymerase II interaction and Def1 requirement for polymerase ubiquitylation in vitro.
###end article-title 108
###begin article-title 109
Roles of BRCA1 and its interacting proteins.
###end article-title 109
###begin article-title 110
The role of BRCA1 in non-homologous end-joining.
###end article-title 110
###begin article-title 111
A Rad26-Def1 complex coordinates repair and RNA pol II proteolysis in response to DNA damage.
###end article-title 111
###begin article-title 112
Spt4 modulates Rad26 requirement in transcription-coupled nucleotide excision repair.
###end article-title 112
###begin article-title 113
###xml 92 116 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Evidence that Spt4, Spt5, and Spt6 control transcription elongation by RNA polymerase II in Saccharomyces cerevisiae.
###end article-title 113
###begin article-title 114
###xml 108 113 <span type="species:ncbi:9606">human</span>
DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs.
###end article-title 114
###begin article-title 115
###xml 63 68 <span type="species:ncbi:4932">Yeast</span>
Functional Characterization of BRCA1 Sequence Variants Using a Yeast Small Colony Phenotype Assay.
###end article-title 115
###begin article-title 116
BRCA1 can modulate RNA polymerase II carboxy-terminal domain phosphorylation levels.
###end article-title 116
###begin article-title 117
C-terminal repeat domain kinase I phosphorylates Ser2 and Ser5 of RNA polymerase II C-terminal domain repeats.
###end article-title 117
###begin article-title 118
Phosphorylation and functions of the RNA polymerase II CTD.
###end article-title 118
###begin article-title 119
###xml 15 20 <span type="species:ncbi:4932">yeast</span>
Involvement of yeast carboxy-terminal domain kinase I (CTDK-I) in transcription elongation in vivo.
###end article-title 119
###begin article-title 120
###xml 120 125 <span type="species:ncbi:4932">yeast</span>
Expanding the functional repertoire of CTD kinase I and RNA polymerase II: novel phosphoCTD-associating proteins in the yeast proteome.
###end article-title 120
###begin article-title 121
BRCA1/BARD1 ubiquitinate phosphorylated RNA polymerase II.
###end article-title 121
###begin article-title 122
BRCA1/BARD1 inhibition of mRNA 3' processing involves targeted degradation of RNA polymerase II.
###end article-title 122
###begin article-title 123
###xml 26 50 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
An essential role for the Saccharomyces cerevisiae DEAD-box helicase DHH1 in G1/S DNA-damage checkpoint recovery.
###end article-title 123
###begin article-title 124
###xml 82 106 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Ccr4-not complex mRNA deadenylase activity contributes to DNA damage responses in Saccharomyces cerevisiae.
###end article-title 124
###begin article-title 125
DNA damage and replication stress induced transcription of RNR genes is dependent on the Ccr4-Not complex.
###end article-title 125
###begin article-title 126
Ccr4 contributes to tolerance of replication stress through control of CRT1 mRNA poly(A) tail length.
###end article-title 126
###begin article-title 127
BRCA1-BARD1 complexes are required for p53Ser-15 phosphorylation and a G1/S arrest following ionizing radiation-induced DNA damage.
###end article-title 127
###begin article-title 128
BRCA1 is a component of the RNA polymerase II holoenzyme.
###end article-title 128
###begin article-title 129
BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A.
###end article-title 129
###begin article-title 130
Physical and functional association of RNA polymerase II and the proteasome.
###end article-title 130
###begin article-title 131
BRCA1 associates with processive RNA polymerase II.
###end article-title 131
###begin article-title 132
BRCT repeats as phosphopeptide-binding modules involved in protein targeting.
###end article-title 132
###begin article-title 133
Role of RNA polymerase II carboxy terminal domain phosphorylation in DNA damage response.
###end article-title 133
###begin article-title 134
Multiple mechanisms confining RNA polymerase II ubiquitylation to polymerases undergoing transcriptional arrest.
###end article-title 134
###begin article-title 135
Ubiquitination and proteasomal degradation of the BRCA1 tumor suppressor is regulated during cell cycle progression.
###end article-title 135
###begin article-title 136
BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations.
###end article-title 136
###begin article-title 137
Evidence that negative elongation factor represses transcription elongation through binding to a DRB sensitivity-inducing factor/RNA polymerase II complex and RNA.
###end article-title 137
###begin article-title 138
Transcription-guarding the genome by sensing DNA damage.
###end article-title 138
###begin article-title 139
RNA polymerase: the most specific damage recognition protein in cellular responses to DNA damage?
###end article-title 139
###begin article-title 140
BRCA1: A locus-specific "liaison" in gene expression and genetic integrity.
###end article-title 140
###begin article-title 141
Decapping and decay of messenger RNA occur in cytoplasmic processing bodies.
###end article-title 141
###begin article-title 142
###xml 44 49 <span type="species:ncbi:9606">human</span>
Cytoplasmic foci are sites of mRNA decay in human cells.
###end article-title 142
###begin article-title 143
BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repair.
###end article-title 143
###begin article-title 144
###xml 107 112 <span type="species:ncbi:9606">human</span>
BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells.
###end article-title 144
###begin article-title 145
Linking transcriptional elongation and messenger RNA export to metastatic breast cancers.
###end article-title 145
###begin article-title 146
###xml 96 120 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Faithful chromosome transmission requires Spt4p, a putative regulator of chromatin structure in Saccharomyces cerevisiae.
###end article-title 146
###begin article-title 147
###xml 35 48 <span type="species:ncbi:4932">S. cerevisiae</span>
Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis.
###end article-title 147
###begin article-title 148
###xml 82 106 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
CTD kinase large subunit is encoded by CTK1, a gene required for normal growth of Saccharomyces cerevisiae.
###end article-title 148
###begin article-title 149
###xml 31 36 <span type="species:ncbi:4932">yeast</span>
###xml 76 81 <span type="species:ncbi:9606">human</span>
A double-strand break within a yeast artificial chromosome (YAC) containing human DNA can result in YAC loss, deletion or cell lethality.
###end article-title 149
###begin article-title 150
###xml 97 121 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Selective inhibitors of the proteasome-dependent and vacuolar pathways of protein degradation in Saccharomyces cerevisiae.
###end article-title 150
###begin article-title 151
###xml 31 36 <span type="species:ncbi:4932">yeast</span>
Immunofluorescence methods for yeast.
###end article-title 151
###begin article-title 152
###xml 30 35 <span type="species:ncbi:9606">human</span>
BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants.
###end article-title 152
###begin p 153
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 153
###begin p 154
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported in part by a CDMRP DOD Breast Cancer Initiative grant DAMD17-03-1-0232 to CBB, a regional grant of the Italian Association For Research on Cancer to AG and a NIH grant CA84955 to JRM.
###end p 154

